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A B S T R A C T 
The human heart cDNA sequencing project is a 
collaborative project between The Chinese University of Hong 
Kong and University of Toronto. During the course of my 
research studies, a novel cDNA clone coding for a putative 
human selenium binding protein was obtained from a human 
heart cDNA library. This full-length human 56 kDa selenium 
binding protein (hSP56) cDNA clone, which is the human 
homolog of mouse 56 kDa selenium binding protein is 
1440bp long and has an open reading frame encoding 472 
amino acids. The calculated molecular weight is 52.25 kDa 
and the estimated isoelectric point is 6.13. Using Northern 
blot hybridization, this 56 kDa selenium binding protein has 
been found to be expressed in mouse heart with an 
intermediate level between those found in liver / lung / 
kidney and intestine. hSP56 has also successfully been 
expressed in E. coli using the expression vector-pAED4. 
Under the conditions used, the hybridization efficiency was 
approximately 8 0 % for the probe we used. The hSP56 gene 
• • 
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has been mapped to human chromosome by fluorescent in 
situ hybridization (FISH). The result shows that hSP56 gene 
is located at chromosome lq21-22. As part of a collaborative 
study, I have sequenced 553 human heart cDNA clones as 
part of my project. I assigned putative identities of these 
clones, set up the database and catalogued the results. 
Notes: 
(1) Accession No. ofhSP56 in GenBank: U29091 
(2) Part of the results in this thesis were published as 
below: 
Peter W. G. Chang, Stephen K. W. Tsui, Choong-chin Liew, Cheuk-
yu Lee, Mary M. Y. Waye, and Kwok-pui Fung. (1997): Isolation, 
Characterization, and Chromosomal Mapping of a Novel cDNA 
Clone Encoding Human Selenium Binding Protein. Journal of 
CeUular Biochemistry 64: 217-224. 
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1.1 General introduction 
In this thesis, I report the partial sequencing of 553 
cDNA clones which I randomly selected directly from a cDNA 
library. I will also describe the cloning, sequencing, tissue 
distribution, gene expression and chromosomal mapping of a 
novel human gene which we named as the human selenium 
binding protein 56 (hSP56). 
The partial sequencing of randomly selected cDNA 
clones directly from a cDNA library has been explored by 
Putney and co-workers in 1983 (Putney et aL, 1983). Using 
this approach to generate expressed sequence tags (ESTs) has 
been shown to be a rapid and efficient way of establishing a 
detailed profile of genes expressed in various tissues (Adams 
et aL, 1991; Adams et al., 1992; Adams et al., 1993; Adams 
et aI., 1994; Collet et al., 1994; Hwang et aL, 1994; Khan et 
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aL, 1992; Liew et aI., 1994; Matoba et al., 1994; Matsubara et 
aI., 1993; Okubo et aL, 1992; Park et aI., 1993; Sikela et aI., 
1993; Tsui et aL, 1994; Waye et al., 1995). ESTs are 
sequences from single sequencing runs of at least 150 base 
pairs with an accuracy of approximately 9 7 % (Adams et al., 
1991). This approach can also be used to discover new genes 
on a large scale. The power and utility of EST data in the 
study of human diseases have also been recently manifested 
in the discovery of a human mutL homologue, which is the 
"Molecule of the Year,, in 1994 (Koshland, 1994), putatively 
involved in hereditary colon cancer (Papadopoulos et al., 
1994). The isolation and sequencing of this homologue were 
tremendously facilitated by the prior availability of EST-
tagged clones corresponding to the gene of interest. 
Information from single-pass sequencing of cDNA clones has 
also been used in many other applications, including the 
generation of physical maps of chromosomes (Chae et al., 
1994; Khan et al., Wilcox et al 1991) and chromosomal 




This thesis will be divided into 4 chapters. In chapter 1, 
the background information relevant to the thesis will be 
provided. Firstly, the genome project, the human adult and 
fetal heart cDNA library will be introduced. Then the 
background of the project will be presented. In addition, the 
background knowledge on the role of selenium will be 
described. The various types of selenium binding proteins 
will be reviewed. Finally, the introduction will be focused on 
an important protein: mouse 56kDa selenium-binding 
protein. The following three chapters will describe the study 
of hSP56. Firstly, in chapter 2, the materials and methods of 
study of hSP56 gene will be reported in detail. This chapter 
will present the method by computer analysis of hSP56 gene 
and the use of the computer for comparing the hSP56 with 
other related proteins such as the mSP56 gene. Then the 
study will show the analysis of hSP56 gene at RNA level and 
the cloning of hSP56 into an expression vector. The results 
may provide the information of the expression 
characterization of the hSP56 gene. Finally, I will describe 
the chromosomal mapping of hSP56. In chapter 3, I wiU 
report the results of sequence analysis, Northern blot 
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hybridization, cloning and expression of hSP56 gene and the 
chromosomal mapping result. Also I will show the sequencing 
result of 553 clones from the human adult heart cDNA 
library and the classification of these clones. Lastly, in 
chapter 4, I will discuss the results of those 553 clones and 
the possible roles of hSP56 and the future prospects for the 
study of hSP56 gene. 
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1.2 Human genome project 
The Human Genome Project (HGP) was initiated within 
the United States Department of Energy (DOE) by Charles De 
Lisi from the Los Alamos Laboratory, New Mexico. A bill to 
fund the HGP was subsequently introduced by Mexico 
Senator Domenici (Rechsteiner et aL, 1991). The HGP first 
took clear form in February 1988, with the release of the 
National Research Council (NRC) report Mapping and 
Sequencing the Human Genome (Olson et aL, 1993). In 1990, 
the Human Genome programs of the National Institutes of 
Health (NIH) and the DOE developed a joint research plan 
with specific goals for the first 5 years (1991-95) of the U.S. 
HGP (Collins et aL, 1993). The initial set of goals are 
constructing detailed human genetic maps, improving 
physical maps of the human genome and the genomes of 
certain model organisms, developing improved technology 
for DNA sequencing and information handling and defining 
the most urgent set of ethical, legal and social issues 
associated with the acquisition and use of large amount of 
genetic information (Collins et al., 1993). 
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In order to construct a high-resolution map of the 
human genome, a new choice of landmarks called sequence-
tagged sites (STS) is required (Olson et al., 1989; Olson et aI., 
1993). An STS is simply a short, unique sequence of DNA 
that can be amplified via PCR. In addition, STSs can be 
described in an electronic database in a form that makes 
them experimentally accessible in any laboratory. The most 
critical aspect of an STS description is the DNA sequence of 
the two primers. Such a high-resolution map will require 
approximately 30,000 equally spaced STSs to achieve a 100 
kb resolution (Olson et al., 1989; Polymeropoulos et al., 
1992). Expressed sequence tags that are obtained from 
random sequencing of human cDNA libraries can be 
converted into STSs (Durkin et al., 1992; Polymeropoulos et 
al., 1992) and become useful resource for human genome 
mapping (Adams et al., 1991; Wilcox et al., 1991). 
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1.3 Human adult heart cDNA library 
The human adult heart cDNA library used in this 
project was purchased from Clontech (Liew et al., 1994). The 
mRNA was prepared from a human adult male heart, 
including some aorta region. The library was constructed 
with lambda gtll as the cloning vector and EcoRI as the 
cloning site. It contains 1.27 X 10^ independent clones. The 
range of insert sizes is 0.4 to 3.4 kb and the average insert 
size is 0.9 kb. This random-primed cDNA library was chosen 
because it is more informative in identifying genes and 
constructing a useful EST database than sequencing from the 
ends of full-length cDNAs (which contain non-coding 5, and 3, 
untranslated sequences) would be (Adams et al., 1991). 
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1.4 Human fetal heart cDNA library 
The human fetal heart cDNA library used in this 
project was obtained from Dr. C. C. Liew,s Lab (Ontario, 
Canada). 6-12 week-old human fetal hearts were used to 
prepare the mRNA for the cDNA library. The library was 
constructed in the expression vector lambda gt22 as the 
cloning vector and NotI- SaIl as the cloning site. The library 
was found to be of adequate complexity, containing greater 
than IX 10 ^ independent clones. Of 60 clones selected at 
random, average insert size was approximately 1.5 kb, with a 
range of 400 bp to greater than 30000 bp [Hwang et al., 
1994]. The information generated by EST sequencing of the 
human fetal heart library has at least twofold significance. 
First, the cataloguing of genes expressed in the developing 
heart will significantly advance the field of molecular 
cardiology [Liew et al., 1994]. The second major impact of 
such sequencing will lie in its contribution to the human 
genome project. It is estimated that by 1998, at a time when 
human genomic sequencing will still be in its infancy, EST 
sequencing will already have identified and completely 
sequenced with an average three-fold redundancy the cDNAs 
of most genes expressed in the human body. 
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1.5 Sequencing of a human heart cDNA clone 
Single-pass sequencing of randomly selected cDNA 
clones to generate sequence tags (ESTs) has been widely used 
to identify novel genes and to study gene expression in a 
variety of tissues (Adams et al., 1991). Our human heart 
cDNA sequencing project is a collaborative project between 
The Chinese University of Hong Kong and University of 
Toronto (Liew et a/” 1993). It is a large scale project that 
aims at sequencing thousands of human heart cDNAs using 
the automatic sequencer. 
I have used a commercially available human heart cDNA 
library and have randomly picked cDNA clones for this 
sequence analysis. The ESTs from the human heart cDNA 
library is a short DNA sequence which represents an 
expressed gene (Adams et al., 1991). The study of this 
project will help to understand the gene expression proHles 
of human heart at different developmental stages and to 
identify novel genes which are specific to human heart (Liew 
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et a/” 1994). It might also help to understand the 
mechanisms that govern the cells, tissues, and organs of the 
human body and to discern the basis of genetic diseases. The 
research in these novel genes may have significance in 
clinical studies. For example, a cDNA clone that is similar to 
some non-human cDNAs will be placed with special attention. 
This gene may be the human homology of , or related to, the 
non-human genes that were matched. 
I have chosen the human heart tissue because 
cardiovascular disease is the most frequent cause of death in 
adult life in industrialised societies, and is increasingly 
important in developing countries. In early life minor 
congenital abnormalities affect 1 in 100 live births and more 
serious abnormalities approximately 1 in 500 (Edwards et a/” 
1996). Our genetic approach of cardiology will complement 
those mainly focused on the consequences of malformation, 
metabolic disorder, auto-immune damage and degenerative 
disease. The heart is not only composed of cardiocytes but 
also other cell types, such as fibroblasts and endothelial 
10 
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cells. It also contains neurovascular components such as 
nerve cells, smooth muscles cells, etc. As a result, certain 
abnormal genetic signals leading to the development of heart 
diseases may be revealed by the sequencing of a 
cardiovascular cDNA library (Michel and Driscoll, White and 
Lalouel, 1988). 
Both human fetal heart and human adult heart cDNA 
libraries were sequenced in our research team study. I have 
chosen both human adult and fetal heart cDNA library in my 
study project, because of the fact that screening human fetal 
heart cDNA library would help to characterize cardiac 
development at a transcriptional level and that it would 
increase the probability of detecting key genes involved in 
developmental and disease processes. The composition of 
ESTs obtained from the fetal heart library differed somewhat 
from that of the adult heart library previously reported (Liew 
et aI., 1994), as evidenced by differences in the proportions 
of known ESTs in several functional categories. Most striking 
was the relative abundance of transcripts representing basic 
11 
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transcriptional and translational (TC/TL) apparatus, as well 
as transcripts representing signal transduction or ceU 
regulatory proteins in the fetal heart, compared with the 
relative lack of such proteins in the adult heart. In contrast, 
the fetal heart appears to express lower levels of transcripts 
representing contractile elements than the adult heart 
(Hwang etaI,1995). 
One of the disadvantages of random cDNA sequencing 
is that highly expressed genes will be sequenced repeatedly 
while the rarely expressed genes may not be included in the 
data base unless a large number of cDNA clones are 
sequenced (Okubo et a/.,1992). 
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1.6 Background knowledge on the role of selenium 
Basic knowledge on the role of selenium in biology and 
human physiology is accumulating at a rapid rate 
(Robberecht and Deelstra, 1994). The first description of 
selenium was published by Berzelius, who obtained a reddish 
precipitate in 1817 while burning pyrite in a sulfuric acid 
plant. Upon analysis of this precipitate, it turned out to be a 
new element. He called the element after Selene, the Greek 
goddess of the moon, as tellurium, which was discovered 
earlier was named after the goddess of earth, Tellus 
(Nebergall et a/” 1968). 
Selenium is an element of subgroup VIA of the Periodic 
Table. This subgroup comprises the non-metals oxygen (0) 
and sulfur (S), the metalloid selenium (Se) and the metals 
tellurium (Te) and polonium (Po). Among these elements the 
close relationship in chemical properties of selenium and 
sulfur is most striking. Due to this chemical similarity, no 




certain biological processes and incorporation of selenium 
and sulfur into proteins occurs in parallel (Hurd et al., 1964). 
There is a wide distribution of selenium throughout the 
earth's crust, similar to that of sulfur. The concentration of 
selenium on earth averages 0.09 ppm but shows a large 
range. Concentration of selenium in soil range from less than 
0.1 ppm in the selenium deficient areas ofNew Zealand to as 
high as 1200 ppm in the organic soil in Ireland 
(Frankenberger et al., 1994). 
During half a century, the public image of selenium 
gradually evolved from that of a highly toxic and 
carcinogenic element to an essential trace element with 
antioxidant and anticarcinogenic properties. The role of 
selenium as a micronutrient has been well established. The 
average daily selenium intake in the 1980s was 40-50 
|ig/day, However, most of the time the selenium dietary 
intake was below the lower limit of the safe and adequate 
intake for selenium as defined by the U.S. National Academy 






jig/day) (Burk. 1995). Deficiency of selenium has been 
associated with reduced life span, anemia, liver necrosis and 
immunological disorders. Selenium deficiency also causes 
structural deformation of sperm tail in rats and muscular 
dystrophy in lambs. Dietary supplementation of selenium 
have been shown to reduce the incidence of cancer of colon, 
liver, intestine, skin, and of mammary glands in animal 
studies (Bansal et aL, 1990). 
Selenium deficiency has also been observed in human. 
This selenium-responsive disease, known as Keshan disease, 
is a juvenile cardiomyopathy occurring in the Heilongjiang 
province of the People's Republic of China. It is the major 
cause of the death for young children. Since the 
administration of 0.5-1.0 mg selenium per week fully 
prevented this disorder, selenium appears to be required at 
about 60-120^ig per day. Selenium uptake from food largely 




1.7 Mouse 56 kDa selenium binding protein and 
acetaminophen-binding protein 
Selenium proteins can be divided into two different 
types. One type is called selenium containing protein, such 
as selenoprotein P and glutathione peroxidase. The 
characteristics of this type of selenium protein is that the 
selenium is present as selenocysteine in the protein (Figl-1 
shows the selenocysteine structure). An in-frame TGA codon 
represents the amino acid selenocysteine. The most 
important of the nucleotide sequence was the presence of 
some in-frame TGA codons in this group of selenium protein. 
Another type of selenium protein is called selenium binding 
proteins such as mouse 56 kDa selenium binding protein 
that are tightly bound with selenium in the body. The 
characteristics of this group of selenium binding protein is 
the absence of TGA codons in the nucleotide sequence. The 
study in selenium containing protein such as selenoprotein P 
is very advanced but research in the group of selenium 
binding protein, both in its function and metabolism are not 
well established (Lanfear et aL, 1993). 
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Fig 1-1 The structure of selenocysteine residue 
NH 
CH-CH2"Se-H 
c = o 
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A review on the mouse 56 kDa selenium binding protein 
for my reseach project is very useful in understanding their 
putative role of the human homolog, because mSP56 is 
similar to hSP56 in nucleotide sequence. From the previous 
study we know that the cDNA clone coding for the mouse 56 
kDa selenium binding protein was isolated by screening a 
XZap mouse liver library (Bansal et al，1990). Their cloned 
cDNA represented the complete message RNA. The correct 
reading frame was verified by alignment of the deduced 
amino acid sequence with that of peptides sequenced from 
the purified protein. The DNA sequence for mouse 56 kDa 
selenium binding protein did not contain an in-frame TGA 
codon that would code for selenocysteine, as occurs in the 
prototypic selenoprotein, glutathione peroxidase. 
Hydropathy analysis suggested that the protein was not a 
membrane-spanning protein. Using antibodies specific for 
mSP56, it was evident that the mSP56 was not induced by 
selenium and was not dependent upon dietary selenium 
levels (Lanfear et al., 1993). 
18 
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A full-length cDNA encoding a 56 kDa liver protein 
implicated in the detoxification of acetaminophen (AP56) has 
been cloned by virtue of its similarity to the 56 kDa 
selenium-binding protein (mSP56): in fact, the deduced AP56 
amino acid sequence differs at only 14 residues from mSP56. 
Isolation of genomic DNA recombinants from a Balb/c mouse 
cosmid genomic DNA library shows that mSP56 and AP56 are 
encoded by two different genes. Using reverse 
transcription / PCR with oligonucleotide primers that 
distinguish the AP56 and mSP56 mRNAs shows that the 
mSP56 mRNA is highly expressed in liver, kidney and lung; 
whereas the AP56 mRNA is mainly expressed in liver. Both 
mRNAs tend to be down regulated in liver cell lines but 
remain high in DEN-induced liver tumours in vivo. The 
relevance of these findings is evaluated in terms of the 
postulated functions of the two proteins in mediating the 
anti-carcinogenic effects of selenium and detoxification 
mechanisms (Lanfear et a/” 1993). 
19 
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Chapter 2 
Materials and methods 
2.1 Plating out the cDNA library 
2.1.1 Media, buffers and solutions 
• IX TBE buffer 
For 1 litre of IX TBE buffer, 10.8g Tris base (Sigma), 5.5g 
boric acid (Riedel-de Haen) and 2 ml 0.5M EDTA (pH8.0) 
(Sigma) was made up to 1 litre with deionized water. 
• Ampicillin (Sigma) 
A stock of 25mg/ml of ampicillin was prepared by dissolving 
2g ampicillin with 80 ml deionized water. The solution was 
stored at -20。C. 
• X-gal (Promega) 
It was purchased from Promega of 50 mg/ml. Then it was 
stored at -20®C. 
• IPTG (Gibco BRL) 
For plating of the library, a stock of 20 mg/ml was made. 
IPTG was dissolved in deionized water and then was 
sterilized by passing through 0.2^im filter membrane 
(Millipore). The solution of IPTG was stored in -20。C. 
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• Suspension medium (SM) 
For 1 litre of SM solution, 5.8g of sodium chloride (Riedel-de 
Haen), 2g of magnesium sulphate (Riedel-de Haen), 50 ml of 
lM Tris-HCl (Sigma) and O.lg gelatin (Sigma) was made up to 
1 litre with deionized water. 
• LB medium and LB plates 
For 1 litre of LB medium, 10g of bacto-tryptone (Difco), 5g of 
yeast extract (Difco) and 10g of sodium chloride (Riedel-de 
Haen) was made to 1 litre with deionized water. For LB 
plates, 15g of agar (Sigma) was added. The medium was made 
up to 1 litre with deionized water and then was autoclaved. 
The autoclaved LB medium with agar was equlibrated at 
55®C. The medium was then poured onto Petri dishes inside 
the hood. 
2.1.2 Bacteriophage clones preparation 
The plating method basically followed that of 
Sambrook et al. (1989). Bacterial host E.coh'Y1090 hsdR was 
grown overnight at 37<>C, 280 rpm in 2 ml LB supplemented 
with maltose (Sigma) (0.2%) and magnesium sulphate (lOmM) 
(Riedel-de haen). The overnight culture was then diluted 
21 
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three fold by LB with 0 .2% maltose and 10 m M magnesium 
sulphate. It was then incubated at 37<>C, 280 rpm for another 
two hours. Then the agar plates to be poured were pre-
warmed at 37®C. LB top agarose was also melted in a 
microwave oven and an aliquot of 3 ml top agarose was 
equilibrated in 55<>C. After two hours of incubation, 100 pfu 
of the fetal human heart cDNA library was added to the 
culture and mixed gently. The culture was then incubated at 
37。C without shaking for 20 min. Upon pouring of the 
library, IPTG (final concentration: 70^ig /ml), X-gal (final 
concentration: 300 i^g /ml) and ampicillin (final 
concentration: 50 1^ /ml) were added to the equilibrated 
molten top agarose. The culture and the top agarose were 
then mixed and poured into the pre-warmed LB agar plates. 
The plates were allowed to cool down for 5 minutes and 
incubated at an inverted position at 37®C overnight. The 
colourless plaques were picked with sterile Pasteur pipettes 
on the next day. The plaques were resuspended in 50 jol of 
SM and were stored at 4°C. 
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2.2 cDNA clone amplification by PCR 
The inserts of each cDNA clone were amplified using a 
pair of primers which is complementary to flanking 
sequences of the Notl and SaR cloning site of Xgt 22A 
vector. The sequence of the primers are: 
Forward: 5, -ATTGGTGGCGACGACTCCTGGA- 3' 
Reverse: 5' -TTTGACACCAGACCAACTGGTA- 3, 
PCR was done by using Taq DNA polymerase 
(Pharmacia) and the composition of reaction mix was: 
Deionized water 36pl 
10X reaction buffer * (Pharmacia) 5^1 
2 m M dNTP mix (Pharmacia) 5|J 
2.5 ^M Primer mix (forward & reverse) 2\A 
Phage stock 2pl 
Taq DNA polymerase (Pharamacia) (2U) 0.4|J 
* 500mM KCL, 15mM MgCl2, 100mM Tris-HCl (pH 9.0 at 
room temperature) 
The reaction mix was then overlaid with 2 drops of 
mineral oil (Sigma). 
The temperature profile of PCR was: 
Step 1: 94®C for 5 min. 
Step 2: 95®C for 36 sec. 
Step 3: 50®C for 36 sec. 
Step 4: 72°C for 1 min. 30 sec. 
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Step 2 to step 4 were repeated for 35 times and then 
followed with a final extension of 72。C for 10 min. The 
success of PCR was checked by running the PCR products in 
1。/。agarose gel stained with ethidium bromide and checked 
with UV. Clones wkh one bright single band were chosen to 
perform cycle sequencing reaction. 
24 
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2.3 Cycle sequencing of PCR products 
2.3.1 Media, buffers and solutions 
• DNA size markers 
DNA size marker X/HindIII-0X174/HaeIII marker was 
purchased from stratagene (Cat#.201107) and X/HindIII-
pUC18/Sau3AI marker. 
• 40 % acrylamide solution 
95g of acrylamide (Pharmacia) and 5g of bis-acrylamide 
(Pharmacia) were dissolved in deionized water and made up 
to 250 ml. It was stored at 4。C. 
• 6 % urea-acrylamide solution 
The solution was made by dissolving 108g urea (Pharmacia) 
into 60 ml 40 % acrylamide solution, 24 ml of 10X TBE 
solution and then made up to 400 ml with deionized water. 
It was then filtered by 0.2^im filter (Millipore). 
2.3.2 Preparation of sequencing reaction 
The cycle sequencing of PCR products was done by 
using one of the following fluorescent primers. The sequence 
of the primers were as follows: 
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Forward: 5, -GGTGGCGACGACTCCTGGAGCC- 3' 
Reverse: 5, -GACACCAGACCAACTGGTAATG- 3, 
The cycle sequencing was done by using cycle 
sequencing kits (Pharmcia Biotech) and the composition of 
reaction mix was as follows: 
Deionized water 10|J 
10x reaction buffer (Pharmcia) 2[d 
4 m M Sequencing primer 2|J 
PCR product 3^1 
2 m M dNTP mix (Pharmcia) 5^J 
DMSO 2^a 
Taq DNA polymerase (Pharmcia) 0.4^J 
6^1 of the reaction mix was pipetted to separate 
Eppendorff tube which had 3^1 of one of termination mix* 
(ddATP, ddCTP, ddGTP, ddTTP). They were then overlaid 
with one drop of mineral oil. 2 m M either of the four ddNTP 
plus 100 M each dATP, dCTP, dGTP, and dTTP. 
The profile of the cycle sequencing reaction was as follows: 
Stepl: 95<>C for 36 sec.; 
Step2: 50°C for 36 sec.; 
Step3: 72。C for 90 sec. 
Stepl to step 3 were repeated 25 times and was then 
followed with a final extension of 72<>C for 10 min. After the 
reaction ended, 5^1 of stop solution was added. 
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2.4 Gel electrophoresis in the automated A.L.F. sequencer 
6 % urea-polyacrylamide gel was made by mixing 60 ml 
6 % urea-acrylamide solution, 280^d 10% APS and 70pl 
TEMED. The running buffer used was 0 .6X TBE. The 
sequencing gel was casted and set for 60 minutes. Then the 
clamps for the comb were removed and the glass plate 
around the comb was cleaned. The upper reservoir was 
attached. After placing the lower reservoir into the 
electrophoresis unit and attaching the anode wire, the 0 .6X 
TBE buffer was poured into the lower reservoir. The gel 
cassette was fitted into the electrophoresis unit and the two 
vertical etched lines were aligned. Afterward, the 
thermoplate was connected and the upper electrode was 
attached to the cathode connector. The main power switch 
was switched on and the computer was turned on. The laser 
beam was adjusted and the 0 .6X TBE buffer was poured into 
the upper reservoir. Water was preheated and the comb was 
removed. The walls were examined and rinsed. The samples 
were denatured by heating at 95®C for 3 min and chilled on 
ice before loading. Then 8^1 of each sample was loaded into 
the wells in the order A, C, G, T. The sequencing gels were 
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run at 40<>C and 34 W for six hours. The laser power was set 
to 3 mW. After six hours, the raw data was processed (Smith 
L. M. 1986). The sequences which are at least 150 bp with an 
accuracy greater than 9 7 % were marked and exported to a 
floppy disk. 
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2.5 DNA sequence analysis 
The raw cDNA sequences of each clone were edited with 
the software A.L.F. manager and the edited sequences were 
sent for comparison with the GenBank and EMBL nucleotide 
and protein databases using the NCBI BLAST electronic mail 
servers (Altschul et aL，1990). The address of the BLAST 
server is "blast@ncbi.nlm.gov". The sequences reported were 
searched against the nonredundant nucleotide sequence 
database by the BLASTN program with an EXPECT value of 
0.75. The EXPECT value is the statistical significance 
threshold for reporting matches against database sequence. 
Lower EXPECT thresholds are more stringent, leading to 
fewer chance matches being reported. Sequence similarity 
identified by the BLAST programs was considered 
statistically significant with a Poisson P-value smaller than 
0.01. The Poisson P-value is the possibility of a score 
occurring by chance, given the number of residues in the 
query sequence and the database (Adams et aL，1991). The 
NCBI RETRIEVE E-mail server (retrieve@ncbi.nlm.nih.gov) 
was used to retrieve the information of a particular match. 
The information retrieved can help us to determine whether 
the fetal human cDNA clones are full length or not. 
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2.7 Transformation of plasmid into competent 
Escherichia coli 
Frozen competent cells were removed from a deep 
freezer and thawed at room temperature until the ceU 
suspension was just thawed. The tube was then placed on ice. 
DNA solution with volume less than 20^1 was added. After 
mixing, the tube was chilled on ice for 45 minutes. The tube 
of cells were heat shocked at 42<>C for exactly 90 seconds 
and then chilled on ice for 2 minutes. The contents of the 
tube were mixed with 800^1 LBG medium (0.2ml lM 
glucose/lOml LB). The tube was then incubated at 37«C with 
shaking (250 r.p.m.) for 45 minutes. The transformed cells 
(diluted to a suitable concentration) were spread onto LB 
agar plates containing the appropriate antibiotics. 
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2.8 Mini-preparation of plasmid DNA (Sambrook et 
a/.,1989) 
A single bacterial colony was transferred from the agar 
plate into 3 ml of LB medium containing the appropriate 
antibiotic. The culture was incubated overnight at 37®C with 
shaking (250 r.p.m.). 1.5ml of the culture was transferred 
into a microfuge tube and then centrifuged at 4000 x g for 
30 seconds. The medium was removed by aspiration. The 
pellet was suspended in 100^J ice-cold Solution I (50mM 
glucose, 2 5mM Tris-HCl pH8.0, lOmM EDTA pH8.0) by 
vigorous vortexing. The tube was left on ice for 5 to 10 
minutes. 200^1 freshly prepared Solution II (0.2M NaOH, 1% 
SDS) was added. The contents were mixed by inverting the 
tube rapidly five times and then left on ice for 5 minutes. 
150^J ice-cold Solution III (60 ml 5M potassium acetate, 11.5 
ml glacial acetic acid and 28.5 ml water in each 100 ml) was 
added. The tube was vortexed in an inverted position for 10 
seconds. The lysate was stored on ice for 15 minutes. 
Bacterial cell debris was spun down by centrifugation in a 
microfuge at 4000 x g for 5 minutes at 4<>C. The clear 
supernatant was transferred into another microfuge tube 
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into which 2 volumes of ice-cold absolute ethanol was added 
to precipitate the DNA. The contents of the tube was mixed 
gently and then stored at minus 20<>C for 20 minutes. 
Precipkated DNA was pelleted by centrifugation in a 
microfuge at 4000 x g for 5 minutes at 4。C. Supernatant was 
discarded and the pellet was washed with 1 ml of ice-cold 
7 0 % ethanol. The pellet was vacuum dried for 20 minutes. 
The DNA powder was dissolved in a minimum volume of 
water containing RNase (20^ig/ml). 
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2.9 Large scale plasmid DNA preparation by Q I A G E N ™ 
A bacterial colony harbouring the plasmid of interest 
was transferred to 250 ml LB medium containing a suitable 
antibiotic, for example, ampicillin (50 mg/ml). The culture 
was incubated at 37<>C overnight with shaking (250 r.p.m.). 
The bacteria suspension was spun down by centrifugation at 
3500 X g. for 20 minutes at 4<>C. The bacteria pellet was 
resuspended in 4.0 ml ice-cold P1 buffer (lOO^ig/ml Rnase A 
in 50 m M Tris-HCl, 10 m M EDTA, pH8.0). vigorous vortexing 
was essential. 4.0 ml P2 buffer (1% SDS, 2 0 0 m M NaOH) was 
added afterwards. The contents were mixed by inverting the 
tube, which were then allowed to stand at room temperature 
for 5 minutes. 4.0 ml chilled P3 buffer (3.0M potassium 
acetate, pH5.5) was added to the tube. The contents were 
mixed by immediate inversion, followed by incubation on ice 
for 15 minutes. The bacteria lysate was centrifuged at 
30,000 X g for 30 minutes at 4。C. 
A QIAGEN-tip 100 (Qiagen Inc, Dusseldorf, FRG) was 
equilibrated with 3.0 ml QBT buffer (750mM NaCl, 5 0mM 
MOPS, 15% ethanol, pH7.0, 0 .15% Triton X-100). The clear 
bacterial lysate was applied onto the column. The column 
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was washed with 10 ml QC buffer (l.OM NaCl, 5 0 m M MOPS, 
15% ethanol, pH7.0) twice. DNA was eluted out of the 
column by 5.0 ml QF buffer (1.25M NaCl, 5 0 m M Tris, 15% 
ethanol, pH 8.2). The DNA solution was mixed with 0.7 
volume of isopropanol which had been equilibrated to room 
temperature. The DNA/isopropanol mixture was spun at 
20000 X g for 30 minutes at 4。C. The DNA pellet was washed 
with ice-cold 7 0 % ethanol and stored at 4<>C. 
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2.10 Cloning the human 56 kDa selenium binding 
protein (hSP56) into the pAED4 vector 
2.10.1 Bacterial strains and vectors 
• Plasmid vector pAED4 
The vector is an expression vector which can be selected by 
ampicillin and induced by IPTG. Upon IPTG induction, the 
strong T7 promoter will recruit T7 RNA polymerase which 
allow the over-expression of the target protein. The vector is 
obtained from Don Doering and Paul Matsudaira. The genetic 
map of pAED4 is shown on Fig. 2-1. 
• Escherichia coli JM109 E. coli JM109 is a common host 
for transformation. The genotype of E. coli JM109 is recPA 
supEAA^ endAl hsdRXl gyrA9^ reMl thi A {lac-proABs 
F'{traD36 proAB" lacIq /ac^AM15}. 
• Escherichia co/iBL21(DE3)pLysS and BL21(DE3)pLysE 
pAED4 is used as the vector (Studier et a/” 1990) for gene 
expression in E.colL It can be selected by chloramphenicol. 
T7 RNA polymerase and T7 lysozyme genes were 
incorporated into the bacterial host. Their genotypes are as 
follows: 
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Fig. 2-1. Schematics diagram fo the p A E D 4 vector. 
T7.Pr: T 7 promotor; T7 .TT : T 7 transcriptional 
terminator; fl(-): intergenic region. 
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Strain Genotype 
BL21 (DE3)pLysS F-, omjft，hsdS (iBvmB ), 
gal dcm (DE3),pi;j^r5 (Cm') 
BL21 (DE3)pLysE F", ompT, hsdS(^ mB ), 
gal,dcm (DE3), i^LysE (Cm') 
2.10.2 Media, buffers and solutions 
• Chloramphenicol (Sigma) 
A stock of 34 mg/ml of chloramphenicol was made by 
dissolving 340 mg of chloramphenicol with 10 ml ethanol. It 
was stored at -20。C. 
• Enzymes 
Ecoia (25U/^1) and Ndel (lOU/^l) were purchased from 
Pharmacia. T4 DNA ligase (1U/^1) was purchased from Gibco. 
• LBA medium and LBA plates 
For LBA medium, ampicillin was added into the LB medium 
which was autoclaved. The final concentration of LBA is 
50^ig/ml. For LBA plates, agar with autoclaved LB medium 
was equilibrated at 55<>C. Ampicillin of 50^1/ml was added 
when necessary. The solution was then poured onto Petri 
dishes inside the hood. 
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• LBAC medium and LBAC plates 
For LBAC medium, ampiciUin (200^g/ml) and 
chloramphenicol (34^J/ml) were added into the LB medium 
which was autoclaved. For LBAC plates, agar with autoclaved 
LB medium was equilibrated at 55<>C. The ampiciUin of 
200^1/ml and chloramphenicol of 34 ^ig/ml were added. The 
solution was then poured onto Petri dishes inside the hood. 
• SOB Medium 
The composition of one litre of SOB is as follows: 
Bacto-trytone (Difco) 20g 
Yeast extract (Difco) 5g 
Sodium chloride (Ridel-de Haen) 0.5g 
250mM Potassium chloride (Ridel-de Haen) 20 ml 
It was made up to one litre with deionized water and 
autoclaved before use. After that, 5 ml of solution of 2M 
MgCl2 (Riedel-de Haen) was added and mixed. 
• SOC Medium 
The composition of 1 litre of SOC is as follows: 20 ml of lM 
glucose (Riedel-de Haen) after sterilization was added to 
980ml of SOB solution after autoclave. 
• Solution I 
50mM glucose (Merck), 25mM Tris-HCl (Sigma) (pH8.0), 
lOmM EDTA (Sigma)(pH8.0). The solution was stored at 4<>C. 
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• Solution II 
0.2M NaOH (Merck), 1% SDS (Sigma). 
• Solution III 
It was made by 60 ml of 5M potassium acetate (Riedel-de 
Haen) and 11.5 ml of glacial acetic acid (Merck) into 28.5 ml 
of deionized water. 
• TFB solution 
10 m M MES (Sigma)(pH6.3), 45 m M MnCl2(Riedel-de Haen), 
10 m M CaCl2(BDH), 100mM Kcl (Riedel-de Haen), 3 m M 
hexamminecobalt chloride(Sigma). 
• DnD solution 
For 10 ml DnD solution, 1.53g DDT(Sigma), 9 ml DMSO(BDH) 
100jJ 1 M potassium acetate (pH7.5)(Ridel-de Haen) were 
made up to 10 ml with deionized water. 
• lXTAE buffer 
For 1 litre IX TAE buffer , 4.84g Tris base (Sigma), 1.142g 
glacial acetic acid (Riedel-de Haen) and 2 ml of 0.5M EDTA 
(pH8.0)(Sigma) was made up to 1 litre with deionized water. 
• 1.5M Tris-HCl (pH8.8) 
For 100 ml of 1.5M Tris-HCl solution, 18.15g Tris base 
(Sigma) was dissolved in 100 ml deionized water. 
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• l.OM Tris-HCl (pH6.8) 
For 100 ml of l.OM Tris-HCl solution, 6g Tris base (Sigma) 
was dissolved in 100 ml deionized water. 
• I X Tris-glycine buffer 
For 1 litre IX Tris-glycine buffer, 3.02g Tris base (Sigma), 
18.8g glycine (Sigma) and 10 ml 10 % SDS (Sigma) was made 
up to 1 litre with deionized water. 
• 10 % (w/v) SDS 
10g SDS (Sigma) was dissolved in deionized water and made 
up to 100mL 
• Protein gel staining solution 
0.2 % (w/v) Commassie blue (Sigma), 2 5 % (v/v) methanol 
(Merck), 10 % (v/v) acetic acid (Merck) was made in deionized 
water. 
• Protein gel destaining solution 
25 % (v/v) ethanol (Merck), 0.08 % (v/v) acetic acid (Merck) 
was made in deionized water. 
• Lysis buffer 
10 m M KC1 (Riedel-de Haen), 10 m M potassium phosphate 
(Riedel-de Haen) (pH7.2), 10 m M DDT (Sigma). 
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2.10.3 Primer design and PCR 
A primer which has its 3, end complementary to the 5, 
end of the open reading frame (ORF) of the cDNA of hSP56, 
an Ndel site overlapping the ATG start codon and a GC clamp 
at the 5, end of the primer was designed. The sequence of 
the cloning primer is as follows: 
5, -TAGGGCCATATGGCTACGAAATGTGGGAATTG- 3, 
Ndel site 
At the other end，an oligo dT primer which acted as an 
universal primer to prime to the polyA tail of the mRNA was 
designed. An Ec6BJ. site was present to enhance later 
subcloning step. The sequence of the dT primer was as 
follows: 
5, -TAGGGCGAATTCTTTTTTTTTTTTTTTTTTT- 3, 
EcoRI site 
The composition of the PCR reaction mix was as 
follows: 
Deionized water 33.7^J. 
plate lysate of hSP56 5^J 
10X reaction buffer*(Pharmacia) 5|il 
5^iM primer mix (cloning and dT primers) 5^1 
2 m M dNTP 5^J 
Taq DNA polymerase (2U) 0.3|il 
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*500mM KC1, 15mM MgCl2, 100mM Tris-HCl (pH 9.0 at 
room temperature) 
The reaction mix was then overlaid with 2 drops of 
mineral oil. 
The temperature profile of the expression-cassette PCR 
was as follows: 
Step 1: 940C for 5min.; 
Step 2: 95®C for 36 sec.; 
Step3: 50°C for 36 sec.; 
Step 4: 72®C for 1 min, 30 sec. 
Step 2 to 4 were repeated for 35 times and then 
followed by a final extension of 72。C for 10 min. The success 
of PCR was checked by running the PCR products in a 1% 
agarose gel stained with ethidium bromide and was checked 
under UV. 
2.10.4 Purification of PCR products by Geneclean 
The method used basically followed the instructions of 
the manufacturer (BIO 101 Inc). PCR product of hSP56 was 
resolved in 1% agarose TAE gel. The gel block corresponding 
to hSP56 was cut and put into an Eppendorff tube. Three 
volumes of NaI solution was then added and the gel block 
was melted by incubation at 55°C for 5 min with agitation. 
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20^1 glass milk was then added and kept at room 
temperature for 5 min. with agitation. PCR products should 
bind to glass milk. The glass milk was then pelleted by a brief 
spin and the supernatant was discarded. The pellet of glass 
milk was washed by resuspending it in 250jJ NEW wash 
solution (provided by manufacturer) which contains NaCl, 
Tris, EDTA and ethanol and then a brief spin. The washing 
was repeated two more times. To elute the PCR product, 20^J 
of deionized water was used to resuspend the pellet of glass 
milk which was then incubated at 55®C for 5 min. The glass 
milk was pelleted by a brief spin and the supernatant was 
collected into another Eppendorff tube. The elution step was 
repeated once using lO^J of deionized water. The eluted PCR 
product was then pooled. 
2.10.5 Restriction digestion of purified PCR product 
and pAED4 
Both purified PCR product and pAED4 vector DNA were 
digested with NdeI and EcoRI (S.K.W. Tsui Ph.D. thesis, 
1995). For the purified PCR product, the following reaction 
mix was prepared: 
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10X One-Phor-All Plus buffer*(Pharmacia) 4|il 
Deionized water 6|J 
Purified PCR product (150ng) 9.0^d 
EcoRL (Pharmacia) (12.5U) 0.5^J 
Ndel (Pharmacia) (5.0U) 0.5^1 
For the pAED4 vector, the following reaction mix was 
prepared: 
10X One-Phor-All Plus buffer*(Pharmacia) 4^1 
Deionized water 5^J 
pAED4 vector (l^g) lO^J 
EcoRL (Pharmacia) (2.5U) 0.5^1 
Ndel (Pharmacia) (5.0 U) 0.5^J 
*lOX One-Phor-All Plus buffer: 100mM Tris-acetate 
pH7.5), 100 m M magnesium acetate, 500mM potassium 
acetate. 
The reaction mixes were incubated at 37°C for 3 hours. 
The restricted PCR product and pAED4 DNA were than 
purified by Geneclean II™ as in section 2.10.4. 
2.10.6 Ligation and transformation of hSP56 
There were four ligation reactions: D1, double-digested 
pAED4 without ligase; D2, double-digested pAED4 with 
ligase; D3, EcoRI-digested pAED4 with ligase; D4, double-
digested pAED4 and PCR product with ligase. For D4, the 
ratio of vector and the insert was set to 1:3. The four 
reaction mixes were as follows: (unit: ^1). 
45 
MATERLVLS AND METHODS 
D1 D2 D3 D4 
Deionized water - 18 18 18 
Vector 5 5 5 5 
5X ligase buffer* 4 4 4 6 
Insert - - - 16 
T4 DNA ligase • 2 2 2 
(Gibco) (1U/^1) 
*5X buffer: 250mM Tris-HCl (pH7.6), 50mM MgCl2 ,5mM 
ATP, 5mM DDT, 25%(w/v)PEG-8000 • 
The reaction mixes were then incubated at 16®C 
overnight. The entire reaction mixes were used for the 
transformation experiments. 
The preparation of competent cells and the 
transformation method were essentially the same as that of 
Sambrook et al. (1989). Firstly, single colony of E. coli JM 
109 was inoculated into 1 ml of SOB. It was incubated at 
37。C overnight. Then 0.1ml of overnight culture was 
inoculated into 10ml SOB and was incubated at 37°C for 3 
hours. The bacterial cells were collected by centrifuging at 
5000 r.p.m. in a 20-2 rotor (Hitachi) for 5 minutes, at 4<>C. 
The pellet was resuspended in 5 ml cold TFB and was 
incubated on ice for 10 minutes. The bacterial cells were 
then collected by centrifuging at 5000 r.p.m. in a 20-2 rotor 
(Hitachi) for 5 minutes, at 4®C. The pellet was then 
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resuspended in 0.6ml TFB. 21^1 of DnD solution was added 
and mixed. The bacterial cells were incubated on ice for 10 
minutes. Another 21^1 of DnD solution was added to the cells 
and mixed again, and the tube was then incubated on ice for 
20 minutes. Aliquots of 210^J. of the bacterial ceU were 
pipetted into 1.5ml Eppendorff tubes. The four ligation 
reaction mixes were then pipetted into separate Eppendorff 
tubes of bacterial cell and mixed. The reaction mixes were 
incubated on ice for 1 hour and then heat-shocked at 42<>C 
for 2 minutes. It was kept on ice for 2 minutes. Then 800^1 
of SOC solution was added into each Eppendorff tube and 
incubated at 37<>C for 45 minutes. Lastly, 1^1, 10^1, 100^J 
were spread on LBA plates and incubated at 37<>C overnight. 
The successfully tranformed bacteria were grown in 2 ml 
LBA medium at 37°C overnight and the plasmids were 
prepared by minipreparation (Sambrook et a/” 1989). 
2.10.7 Screening and purfication of pAED4-hSP56 
Mini-preparation (Sambrook et al., 1989) was used to 
screen for recombinant pAED4-hSP56. 1 ml of overnight 
culture was centrifuged at 3500 x g at 4<>C for 30 sec. using a 
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microcentrifuge. The pellet was then resuspended in 100|J 
solution I and mixed well. 200^J of solution II was added and 
mixed by inverting the Eppendorff tube several times. Then 
150|il solution III was added and mixed. The solution was 
incubated on ice for 5 minutes. It was then centrifuged at 
20000 X g at 4°C for 10 minutes. The supernatant was 
collected and the plasmid was precipitated by adding 2 
volumes of ice-cold absolute ethanol and stored on ice for 10 
minutes. The solution was then centrifuged at 20000 x g at 
40c for 10 minutes. The pellet was washed with 7 0 % ethanol 
and dried. Lastly, the pellet was dissoved in the desired 
volume of deionized water. The plasmid was stored in -20<>C. 
The mini-preparation of pAED4-hSP56 was performed 
by using a commercially available plasmid-adsorbing column 
(Qiagen). 30 ml of overnight culture in LBA bearing the 
desired plasmid was inoculated into 500 ml LBA. It was 
incubated at 37®C for 12 hours. The culture was then 
centrifuged at 2500 x g at 4<>C for 10 minutes. The pellet was 
resuspended in 100 ml ice-cold IX STE and then centrifuged 
at 2500 X g at 4®C for 10 minutes. The pellet was then 
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resuspended in 4 ml P1 solution (lOO^ig/ml Rnase A [Sigma], 
5 0 m M Tris-HCl, lOmMEDTA [pH8.0]) and mixed. Then 4 ml 
ofP2 solution (200mMNaOH,l% SDS) was added and mixed. 
The solution was kept at room temperature for 5 minutes. 4 
ml of P3 solution (2.55 M potassium acetate [pH4.8]) was 
added and mixed gently. The solution was then centrifuged 
at 35000 X g at 4°C for 30 minutes. The suspernatant was 
saved and loaded onto a QIAGEN-pack 100 cartridge which 
was pre-equilibrated with QB solution (750mM NaCl, 5 0mM 
MOPS, 15% ethanol [pH7.0]). The flow rate was kept at 1 
drop/sec. The cartridge was washed two times with 4 ml of 
QC solution (l.OM NaCl, 50mM MOPS, 15% ethanol [pH7.0]). 
The flow rate was kept at 2 drops/sec. Then the plasmid was 
eluted from the cartridge by using 2 ml of QF solution (1.2M 
NaCl, 50 m M MOPS, 15% ethanol [pH8.0]). The flow rate was 
kept at 1 drop/sec. 0.5 volume of isopropanol was added to 
the elute and kept on ice for 30 minutes. The solution was 
centrifuged at 35000 x g in 20-2 rotor (Hitachi) at 4<>C for 30 
minutes. The pellet was washed with 7 0 % ethanol and dried. 
The pellet was dissolved in an appropriate volume of 
deionized water and stored at -20。C. 
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2.11 Expression of hSP56 
2.11 • 1 Induction of hSP56 expression 
The expression system that we have utilized was the T7 
RNA polymerase expression system which can overexpress 
the target protein using E coli as the host (Studier et 
a/.,1990). The procedure of hSP56 expression was basically 
the same as that of Studier et al. (1990). Firstly, single 
isolated transformed clones of BL21(DE3)pLysS and 
BL21(DE3) pLysE plated in LBAC plates were picked and 
inoculated into 5ml of LBAC medium which were allowed to 
grow at 37®C at 250 r.p.m. overnight. The overnight cultures 
were inoculated into another flasks of 50 ml LBAC medium 
at a concentration of 1% culture. The cultures were allowed 
to grow at 37<>C at 250 r.p.m. until ODeoo reached 0.5-1. It 
took approximately 3 hours. 50 ml culture was then 
inoculated into 1 litre of LBAC medium and allowed to grow 
at 37®C at 250 r.p.m. until ODeoo reached 0.5-1. It took 
approximately 5 hours. A final concentration of 0.4 m M IPTG 
and 0 .2mM ZnSO4 were added to start the induction. The 
induction lasted three hours. 1 ml of culture was pelleted 
and resuspended into 100^J of IX SDS gel-loading buffer to 
check if hSP56 was expressed. The remaining cultures were 
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collected by centrifuging the culture at 3500 x g at 4。C for 
10 minutes. The pellets were then resuspended in 1 /50 of 
volume of lysis buffer. The bacterial cells were sonicated and 
the cell debris was removed by centrifugation at 20000 x g 
for 30 minutes at 4®C. 
2.11.2 SDS-PAGE and protein detection 
Laemmli buffer system (1970) was used for the analysis 
of proteins. The composition of the 15 % resolving gel is as 
follows: 
Deionized water 3.55 ml 
1.5M Tris-HCl (pH8.8) 2.5 ml 
10 % (w/v) SDS 0.1 ml 
4 0 % acrylamide/bis- acrylamide solution 3.75 ml 
10% (w/v) ammonium persulphate (Serva) 0.1 ml 
TEMED (Pharmacia) 4.0^d 
The mini-gel was casted as directed from Bio-Rad. The 
resolving gel was poured between the mini-gel plates and was 
layered with water-saturated isobutanol (Mallinckrodt). The 
gel was set for 45 minutes. Afterwards, the layer of water-
saturated isobutanol was cleaned up and the plates were 
dried. 5 % Stacking solution is as follows: 
Deionized water 3.64 ml 
1.0 M Tris-HCl (pH6.8) 0.63 ml 
10 % (w/v) SDS 0.05 ml 
40 % acrylamide/bis-acrylamide solution 0.61 ml 
10 % (w/v) ammonium persulphate (Serva) 0.05 ml 
TEMED (Pharmacia) S.O[d 
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It was then poured between the mini-gel plates and a 
comb was inserted from the top of the gel. The gel was set for 
I hour. Just before running of protein samples, the samples 
were boiled for 5 minutes. The protein gels were then run in 
I X Tris-glycine buffer of constant current 70 mA (for two 
gels ) for about 1 hour. 
The gel may be stained with Coomassie blue. Coomassie 
blue staining method can detect proteins present in the 
polyacrylamide gels at a i^g level. Coomassie blue staining 
was done by immersing the protein gels into the protein gel 
staining solution overnight with gentle agitation. The protein 
gels were then destained in protein gel destaining solution 
with gentle agitation. The protein destaining solution was 
changed several times until the protein gels were destained 
to the desired intensity. 
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2.12 Northern hybriddization ofhSP56 
2.12.1 Animal & human tissue 
Spraque-Dawley rats were used to prepare total RNA. 
The fetal human heart tissue was from an aborted fetus. 
2.12.2 Preparation ofmedias, buffers and solutions 
For those solutions which were involved in the analysis 
of RNA, they were treated with DEPC (Sambrook et al., 1989). 
Briefly, DEPC (Fluka) was added to solutions (0.1% (v/v). The 
solutions were agitated and autoclaved. However, those 
solutions which were composed of Tris base were not treated 
in this way. Instead, Tris base was directly dissolved in 
DEPC-treated deionized water. 
• 0.5 M EDTA (Sigma) 
186.1 g EDTA disodium salt/ dihydrate (Sigma) was dissolved 
in deionized water and make up to 1 litre (pH 8.0). It was 
then autoclaved. 
• 5X formaldehyde gel-running buffer 
0.1 M MOPS (pH7.0) (Sigma), 40 m M sodium acetate (Merck), 
5mM EDTA (pH8.0) (Sigma). 
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• Formaldehyde gel-loading buffer 
50 % glycerol (Sigma), 1 m M EDTA (pH8.0) (Sigma), 0.25 % 
bromophenol blue (Sigma), 0.25 % xylene cyanol FF (BDH). 
• 2 0X SSC 
For 1 litre 20X SSC, 175.3g sodium chloride (Riedel-de Haen) 
and 88.2g sodium citrate (Amresco) were dissolved in 800 ml 
deionized water. They were then adjusted to pH 7.0 with 
10M NaOH (Merck). The volume was adjusted to 1 litre with 
deionized water and was autoclaved. 
• 20X SSPE 
For 1 lkre 20X SSPE, 175.3g sodium chloride (Riedel-de 
Haen), 27.6g NaH2PO4-2H2O (Riedel-de Haen) and 7.4g EDTA 
(Sigma) were dissolved in 800 ml deionized water. The pH 
was then adjusted to 7.4 with 10M NaOH (Merck). The 
volume was adjusted to 1 litre with deionized water and was 
autoclaved. 
• I X STE 
O.lM NaCl (Riedel-de Haen), lOmM Tris-Cl (pH8.0), l m M 
EDTA (pH8.0) (Sigma). 
• l X T E 
lOmM Tris-Cl (Sigma), lmM EDTA (pH8.0) (Sigma). 
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• CsCl/EDTA solution 
5.7MCsCl (Gibco BRL), 0.01M EDTA (pH7.5) (Sigma) 
• RNA extraction buffer 
To prepare 50 ml, 25g of guanidinium thiocyanate (Gibco 
BRL), 2.64 ml of 10 % sodium lauryl sarcosinate (Sigma), 
0.36 ml of p-mercaptoethanol (Riedel-de haen), 1.76 ml of 
0.75M sodium citrate (Amresco) was added. 
• Guanidinium thiocyanate homogenization buffer 
4.0M guanidinium thiocyanate (Gibco BRL), O.lM Tris-Cl 
(pH7.5)(Sigma), 1% p-mercaptoethanol (Riedel-de Haen). 
• 100X Denhardt,s reagent 
For 500 ml of 100X Denhardt,s reagent, 8g of Ficoll (Sigma), 
8g of polyvinylpyrrolidone (Sigma) and 8g of bovine serum 
albumin (Sigma) was dissolved in 500 ml DEPC-treated water. 
It was then sterilized by filtration and stored at -20。C. 
• Solution A 
0.32 M sucrose (Sigma), lOmM Tris-HCl (Sigma) (pH7.5), 5 m M 
MgCl2 (Riedel-de Haen), 1% TritonX-100(v/v) (Sigma). 
• Solution B 
4Mguanidinium thiocyanate(Gibco BRL), 2 5mM sodium 
acetate(pH4.8),0.84%(v/v) p-mercaptoethanol (Riedel-de 
haen). 
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2.12.3 Preparation of total RNA 
The AGPC method (Chomczynski and Sacchi, 1987) was 
used to prepare total RNA from rat tissues. This method is 
suitable for small scale preparation of total RNA • For 100mg 
of tissue, 1 ml RNA extraction buffer was added for 
homogenization with a glass homogenizer. 100^J of 2M 
sodium acetate (pH4) (Merck) was added and mixed. 1 ml of 
Tris-saturated phenol (Gibco BRL) and 200^1 of chloroform 
(Merck): isoamy alcohol (Merck) (49:1) was then added and 
the solution was vortexed for 20 sec. The solution was kept 
on ice for 15 minutes. The solution was then centrifuged at 
15000 r.p.m. for 20 minutes at 4°C in a microcentrifuge. The 
upper aqueous layer was carefully transferred to another 
Eppendorff tube. 1 volume of ice-cold isopropanol (Riedel-de 
Haen) was added and the solution was kept at -20<>C for 20 
minutes. The solution was centrifuged at 12000 x g in a 
microcentrifuge for 10 minutes at 4®C. The supernatant was 
discarded and the RNA pellet was washed with 70 % ethanol 
(Merck). The pellet was then dried and dissolved in 0.5 % 
SDS or DEPC-treated water. 
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2.12.4 Formaldehyde agarose gel electrophoresis 
The method used was based on that of Sambrook et al. 
(1989). The 1.5 % agarose/2.2 M formaldehyde (Riedel-de 
haen) gel was prepared by mixing 0.74g agarose (Sigma) with 
30.6 ml deionized water and 9.9 ml 5X formaldehyde gel-
running buffer. The agarose/water solution was melted by 
microwave for 2 minutes, at medium power. 9 ml 
formaldehyde was then added to the melted agarose solution 
and was poured to the gel cast. The gels were set in a flow 
hood. The RNA samples were prepared as follows: 
RNA (40^ig) 5.0^a 
5X formaldehyde gel-running buffer 2.0^1 
formaldehyde (Riedel-de Haen) 3.5^1 
formamide (Amresco) lO.O^J 
The sample were incubated at 65。C for 15 minutes, and 
then chilled on ice. 2jJ of formaldehyde gel-loading buffer 
and 1^1 of ethidium bromide (lmg/ml) was then added. The 
samples were run in the gel submerged in IX formaldehyde 
gel-running buffer at 30V. The gel was collected when the 
dye front has migrated to 3 / 4 of the gel. The gel was 
inspected above the UV light box to see if the RNA was intact 
and well separated. 
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2.12.5 Preparation of radioactive probe 
The method of random priming (Vogelstein and 
Peinberg, 1983) was used to prepare radioactive probes. The 
procedure followed the instruction of the manufacturer 
(Megaprime™, Amersham). Briefly, 2jil of template DNA 
obtained by using PCR primers of the following sequences 
5'TAGGGCCATAGCCCAAGTGTCCCAAGTGC 3, and 5' 
AGGATGGGTCTCCACCACCTG 3' and the PCR product (about 
25ng) was mixed with 5^1 of 9-mer primer mix provided by 
the manufacturer and 26jJ deionized water. The mixture was 
then boiled for 5 minutes. It was chilled on ice and then lO^J 
of labelling buffer (Amersham), 5^J of [a-P32] dCTP (10 uCi. 
Amersham) and 2^J of Klenow fragment (Amersham) were 
added to the mixture. The reaction mix was incubated at 
37®C for 1 hour. The reaction was stopped by adding 5^J of 
0.2M EDTA. The reaction mix was then passed through a IX 
STE equilibrated NucTrap© push column (Stratagene) to 
remove unincorporated nucleotides from the radiolabeled 
DNA probe. Then 75jJ lXSTE was added to the column to 
facilitate the collection of purified radioactive probe. The 
purified radiolabeled probe was then denatured by boiling for 
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3 minutes. It was then added to the hybridization solution 
after RNA transfer and prehybridization of the membrane. 
Although the exact CPM of the probe was not determined by 
Scintillation counting, a reading of 150-200 CPS (counts per 
second) on the hand held gamma radiation counter (mini 
monitor 900, Mini instruments LTD) is usually detectable 
when it is held 1 cm away from the labelled probe which is 
resuspend in 50 ^1 solution in a 200 yd (Sarstedt) microtube. 
2.12.6 RNA transfer and Northern hybridization 
The formaldehyde /agarose gel after electrophoresis of 
total RNA was rinsed for three times with DEPC-treated 
water. The gel was then immersed in 20X SSC for 20 minutes 
with gentle agitation. A 3MM Whatman paper was used to 
mark a bridge which transfer the buffer to the geL The gel 
was placed on the bridge in an upside-down orientation. The 
transfer buffer used was 20X SSC. 3MM Whatman papers 
were soaked in 2X SSC for 3 minutes. Nylon membrane was 
equilibrated in 20X SSC for 10 minutes. It was carefully 
layered on the geL Three sheets of 3MM Whatman paper pre-
soaked in 2X SSC was layered on the Nylon 
membrane.Bubbles were carefully removed. Then a stack of 
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paper towel was added to the top of the 3 M M Whatman 
papers. The transfer proceeded overnight. The efficiency of 
RNA transfer was checked by studying the intensity of 
fluorescence of EtBr that remained in the gel. The Hybond-N 
nylon membrane onto which the electrophoresized RNA were 
transferred was washed with DEPC-treated 6X SSC for 5 
minutes. It was allowed to dry at room temperature for 15 
minutes. The nylon menbrane was baked under vacuum at 
80®C for 1 hour. The nylon membrane may be stained by first 
immersing the membrane in 5 % acetic acid (Riedel-de Haen) 
for 10 minutes. Then the membrane was stained by 
membrane-staining solution (0.5 M sodium acetate {pH5.2} 
{Merck}, 0 .04% methylene blue) for 5 minutes. The 
membrane was then destained in deionized water until 
desired results were obtained. Upon prehybridization, the 
nylon membrane was pre-wetted in 6X SSC for 15 minutes. It 
was then incubated at 42°C for 6-8 hours with the following 
prehybridization solution: 
formamide (Amresco) 10 ml 
100X Denhardt's reagent 1 ml 
20X SSPE 6 ml 
10% SDS (Sigma) 1 ml 
lOmg/ml sperm DNA* (Sigma) 0.2 ml 
DEPC-treated water 1.8 ml 
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*lOmg/ml sperm DNA was boiled for 5 minutes just 
before use. 
After prehybridization, the membrane was hybridized 
with radio-labelled probe as prepared in section 2.12.5. The 
hybridization solution is described as follows: 
formamide 10 ml 
20X SSPE 6 ml 
10% SDS 1 ml 
DEPC-treated water 2.8 ml 
radioactive probe 100^J 
The hybridization was carried out at 42°C for 20 hours 
with gentle agitation. The nylon membrane was then washed 
2 times with IX SSC/0 .1% SDS at room temperature for 5 
minutes. It was then washed once with O.lX SSC/0 .1% SDS 
at room temperature for 5 minutes. Then the membrane was 
put into the cassette and autoradiographed at -70®C for 48 
hours. After that, the cassette was removed to room 
temperature for about 2 hours before developing the film in 
the dark room. 
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2.13 Chromosomal mapping of the hSP56 gene 
The chromosomal mapping of the hSP56 gene was 
performed by Dr.H.H.Q. Heng of SeeDNA Biotech Inc. 
(Ontario, Canada). The pAED4-hSP56 plasmid was 
biotinylated with dATP using the BRL (Gaithersburg, MD) 
BioNick labelling kit. The procedure for fluorescent in situ 
hybridization (FISH) detection was performed essentially as 
described by Heng et aL [1992] and Heng and Tsui [1993]. 
62 
RESULT 
C H A P T E R 3 
R E S U L T S 
3.1 The sequencing results of 5 53 cDNA clones 
I have sequenced 553 adult human heart cDNA clones 
from the cDNA library using the automatic sequencer, assigned 
putative identities of aU the clones, organized the database of 
these ESTs and analysed the results of the computer search. 
Novel sequences (no significant match with known gene) and 
sequences that match to other human ESTs only were 
submitted to GenBank. The criteria for submission were that 
sequences with no ambiguities for at least 150 base in length. A 
summary of results is shown in Table 3-1. 
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Table 3-1. Categories of cDNA from adult human heart cDNA 
library. 
BLASTN search result Number of clones % 
Alu repeat 16 2 . 9 
Mitochondrial 161 29 . 1 
Novel 153 2 7 . 7 
Repetitive 9 1.6 
Ribosomal R N A 7 1.3 
K n o w n 2 0 7 3 7 . 4 
Total 553 100 .0 
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3 .2 Catalogues of genes expressed 
I have analysed 346 novel genes and 207 known genes in total. 
To study the pattem of gene expression in the adult human 
heart, 207 clones are categorized into ten groups: contractUe 
elements cytoskeleton and related proteins, extraceUular 
matrix proteins, proteins involved in energy metabolism, 
hormones and proteins involved in hormonal regulation, 
proteins that participate in signal transduction and ceU 
regulation, proteins of transcriptional and translational 
machinery, membrane associated proteins, proteins involved in 
other metabolism and misceUaneous proteins (Table 3-2). A 
summary of 207 c l o n e s homologous to known genes is shown 
in Table. 3-3. 
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Table 3-2. Expression profiles of adult human heart 
cDNA library 
Category Number of clones (%) 
Contractile element 3 5 16.9 
Cytoskeleton related 18 8 . 7 
Extracellular matrix S 1.4 
Energy metabolism 2 4 11.6 
Hormones and hormonal control 10 4 .8 
Signal transduction/cell regulation 7 3 .4 
Transcription and translation 38 ISA 
Membrane associated 11 ^-^ 
Other metabolism 3 7 17.9 
Miscellaneous 2 4 11.6 
Total 2 0 7 100 .0 
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Table 3-3. Human cardiac ESTs which are matched to 
known genes in the GenBank and EMBL databases. For the 
clone number, the first alphabet and the following three 
numbers indicate the identity of the clone in our library 
and the ‘F, indicates the cDNA clones were sequenced by 
using forward primer. 
Clone no Gene-ID Accession Length(bp) %-ID 
(1) Contractile elements 
X080-F Hunan nyoain light chain 1 , ventriaular cnb|X07373| 247 二 
T701-P Human troponin T , cardiac gb|L40162| 384 ®» 
U117-F Hrnnan actin, cardiac alpha gb|J00068| 242 94 
908-F Hmnan nyosin light chain 2 , ventricular gb|S69022| 236 " « 
T834_r Huroan n^osin light chain 2 , ventricular gb|S69022| 290 »» 
Tl62-P Hmnan n^osin light chain 2 , cardiac gb|M22815| 270 ®® 
T061-P Human n^osin light chain 2 , cardiac gb|M22815| 380 99 
T202-F Rat calsequestrin gb|U33287| 390 " 
T656-r Human troponin T , cardiac cnto|X74819| ^50 99 
T905-F Hunan nyosin heavy chain, cardic b«ta gb|M21665| 243 91 
T027-P Human n^osin heavy chain, cardic beta gb|M25137| 170 19 
T505-F Human rtyosin heavy chain, cardic beta cni>|X05631| 240 »« 
T677-F Human xnyosin heavy chain, cardic beta gb|M21665| 188 »® 
T601-P Hunan n^osin alkali light chain, non-muscle gb|M22918| 336 9B 
U198-F Human nyosin alkali light chain, ventricular gb|M24248| 252 91 
T808-r Huroan nyosin heavy chain, cardic beta gb|M21665| 305 ®® 
T203-r Human nyoain heavy chain, cardic beta gb|M21665| 220 ®3 
T773-F Human nyosin heavy chain, cardic beta «nb|X05631| 177 ®* 
T076-P Human nyosin light chain 2 , ventricular gb|S69022| 260 92 
T621-F Kunan actin, alpha «tto|X00351| 197 " 0 
U072-F Hwnan actin, oardiac alpha oib|X03767| 153 »» 
T722-P Human xtyosin regulatory light chain enb|X54304| 196 9* 
T880-F Human nyosin regulatory light chain crtto|X54304| 417 ®8 
T594-r Huraan nyosin regulatory light chain ento|X54304fc 301 »6 
T042-F H\nnan nyoain light chain 2 , ventricular gb|S69022| 160 ®® 
T133-F Htunan troponin T , cardiac gb|L40162| 263 “ ® 
T466_P Hmnan troponyoain, skeletal alpha gb|M3-9713| 395 ®® 
T503-F Htunan tropora/oain, skeletal alpha gb|Mn.9714| 269 ®® 
U042-F Hmnan tropcnyosin, skeletal alpha gb|M3-9714| 165 93 
T803-r Huroan troponin C, slow skeletal enb|X07897| 215 98 
T726-F Human troponin C, slow skeletal crrb|X07897| 178 98 
T538-F Hmnan troponin C, slow skeletal ento|X07897| 194 6B 
T721-r Hmnan troponin I , cardiac crtto|X54163| 236 91 
T442-F Human troponin T, cardiac crrb|X79857| 264 9S 
{2) Extracellular matrix 
T627-P Huroan chondroltin/dexroateui aulfat® proteoglycan gb|M14219| 202 99 
T875-F Hiunan thronbospondin-4 ento|Z19585| 210 85 
T861-F Huroan gap junction protein, cardiac cnto|X52947| 157 100 
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(3) Cytoskeleton and related protein 
U112-P Human sk®letal raiscl« 190 kDa protein «nto|XS9090| " 1 ®® 
T095-r Hmnan desxoin gb|M63391| 390 " 0 
U067-r Human roajor nuclear roatrix protcin gb|M63483| J30 
T192-P Hmnan d«3n»plakln gb|J05211| " 5 »® 
T645-r Hmnan desndn ^yb|MW3W| « 3 93 
T205-r Hvman <te3min ^^ l""391| "0 99 
T982-r K _ a n <tesndn g b | M 6 3 3 ^ " f ®J 
U171-r Hrnnan crystal l in , alpha B gb|S45630| fJ7 二 
T390-F Hmnan cat«nin , alpha dbj|D13866| 119 91 
u202-r Hmnan beta-sarcoglyoan dystrophin-aaaociat«d glyooprogb|U29586| 192 » ' 
T417-F Hmnan act in in , skcletaO. alpha-2 gb|M86406| ^ 巧 ” 
T003-r Kuxnan t i t i n 她 1 二 二 ！ ？ " “ 
T995-r Hmnan t i t i n « r b | X M 4 9 0 | 252 9B 
T472-r Hu»an t i t i n ento|X90568| 269 96 
T469-F Hmnan t i t i n «nb|3C90S6B| 293 9B 
T450-F Huxnan t i t i n «rb|X90S68| 315 91 
T449-F HT^nan t i t i n «rb|X90568| 347 99 
X7ll-F Hunan actin depolyroerization factor gb|S65738| 385 98 
(4) Energy metabolism 
U043-P Hmnan cytochrome bc-1 conplex core protcin I I gb|J04973| 231 ®® 
T665-F Hwnan pyruvate dehydrogenase El-alpha svOiunit gb|L48690| 325 »® 
XJl22-P Hmnan roalate dehydrogenase, cytoaolic dbj|D55654| 161 »= 
T863-F Hunan lipoprotein lipase enb|X54516| 252 二 
Ul76-F Hiunan glucose phosphate iaoroerase gb|M55538| 167 »» 
T566-F Hmnan cytochrome c oxidase , subunit Va gb|M22760| 175 ®® 
U174-F Hunan cytochrome c oxidase , subunit V Ic cnto|X13238| 197 ®® 
U134-P Human cytochrome c oxidase, subunit V I I c cnb|X16560| 166 10 
T345-P Human cytochrome o oxidase, subunit V l I c crtto|X16560| 160 91 
T760-F Hmnan cytochrome c oxidase, subunit VTIc ertto|X16560| 257 »® 
T980-r Hunan cytochrome c oxidase, aubunit VXDi ento|Z14244| 176 91 
U074-F Hianan cytochrome o oxidase, subunit V I I I gb|J04823| 166 二 
U203-P Hwnan cytochrome bc-1 conplex core protein I I gb|J04973| 239 99 
U048-F Cow ATP synthetase, ndtoohondrial epsilon subunit ento|m6978| 211 ®® 
T218-F Human creatine kinase , « « s c l « gb|M21494| 113 ®® 
T256-r Human creatine kinase , mitochondrial gb|J05401| 235 ^ ° ° 
T964-r Hunan creatine kinas®, ndtochondrial gb|J05401| 157 ” 
T299-F Hunan calcimti-ATPase gb|M23115| 1B1 »J 
Ul59-F Human ubiquinol cytochrome c reductase core I proteingb|L168421 211 *" 
T030-F Human NADH-ubiquinonc oxidorcductase gb|M22538| 236 ®® 
T187-F Hiunan Fl-ATPase beta, subunit enb|X03559| 206 »1 
X865-F Human ATPasc coupling factor 6 siobunit, mitochondrialgb|M371041 312 95 
U057-F Cow NADH ubiquinone oxidorcducta3e, MLRQ subunit cnto|X64897| 319 63 
T684-F Cow PlFO-ATP synthase conplcx P0 mercbrane domain g sugb|S70448| 379 89 
(5) Hormones and hormonal control 
T596_F Human tunor necrosis factor alpha inducible protein Agb|M59465| 355 98 
T424-F Human brain natriuretic protein gb|M25296| 279 99 
T715-F Hvunan cardiodilation atrial natriuretic faotor gb|M30262| 295 93 
X094-F Hmnan cardiodilation atrial natriuretic factor gb|M30262| 334 91 
X929-r Hmnan cardiodilation atrial natriuretic factor gb|M30262| 206 98 
T064-F Hunan cardiodilation atrial natriuretic factor gb|I01397| 192 99 
T811-r Human Interferon-induodLble genc l-8U enb|X573521 250 99 
T795-F Human prolactin receptor-aasociatcd protcin gb|M18981| 313 93 
T091-P Human prostaglandin D synthase gb|M61900| 215 92 
r m - F Rat vascular endothelial growth factor gb|U22372| 303 98 
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(6) Membrane associated 
T262-r Rat integral menbrane glycoprot«in eni>|Z21513| 310 ®^ 
T812_F Hrnnan leukemia virus receptor 1 gb|L20859| 256 ' ^ 
T706-F Hiunan glycosylated sur£ac« protein ento|X06296| 338 • * 
U128-F Hiunan pl90-B gb|U17032| 247 92 
U212-r Hunan nuclcoporin-like protein «rto|X89478| 220 * " 
T928-F HTunan nucleoporin NUP358 gb|L41840| 393 l = 
X989-r Hunan nucleoporin NUP358 dbj|D42063| 19€ »» 
T352_r Hunan glutanato rcceptor f l ip isoform gb|U10301| 163 9* 
T569-r Hwnan axonal transport«r «nto|X90840| 200 16 
T91Q.r Human myoblast cell surfactt antig«n 24 asb|X16850| 222 *^ 
T628_r Human mentoran« glycoprotein 4F2 antigen heavy chain gb|J02939| 345 97 
(7) Miscellaneous 
T673-F Human R^rosln gb|M59832| 337 90 
T870-F Htonan homolog of rat HREV107-like protein cnto|X92814| 308 »» 
T766-F Hunan histidinc-rich calcium binding protein gb|M60052| 401 97 
T573-F Human noesin gb|M69066| " 0 99 
T841-F Hmnan neurodapl dbj|D32249| 357 91 
T878-F Htunan platelet-endothelial tctraspan antigen 3 gb|U14650| 160 98 
T710-F Hunan porin g b | L 0 8 S ^ | 316 91 
T90l-p Rat nuclear pore oonplex protcin NUP107 gb|L31840| 380 »= 
T576-r Huroan supressor for yeast nutant dbj|D66904| 201 ®® 
U216-P Hrnnan highly basic protcin, 23 kDa crtb|X56932| 231 96 
T509-r Human growth factor inducible intermediat® cnb|X56790| 321 15 
T888-F Hmnan vlsinin-lik« peptide 1 h<anolog gb|U14747| 260 ®J 
T660-F Hurnan vinculin gb|M33308| 323 91 
T679-F Wm>an<tecorin gb|M98262| " 1 ^5 
X616-F Hunan calcyclin gb|J027S3| 379 99 
T132-P Huxnan Tob dbj|D38305| 2 ” 100 
U051-F Hun>an OXAlHs «nto|X80695| 208 94 
T216-r Human Ki nuclear autoantigen gb|U11292| 365 »® 
T272-F Hmnan ETS2 enb|X55181| 208 95 
T741-F Hmnan DS-1 enb|X81788| 317 9J 
T599-F Hun>anDGCR6 «rtto|X96484| 293 95 
T001-F Huxnan Csa-19 gb|U12404| 2 ^ 100 
0J904_r Huroan CAC and GT6 repeat_containing mRNA gb|U00943| 246 91 
T160-r Hmnan BT61 eob|X61123| 316 99 
(8) Other metabolism 
T313-r Htunan ntttallothionein I-G gb|J03910| 295 91 
Ul48-P Human inositol phospholipid assenbly protein gb|S74936| 310 98 
T658-F Huroan long-chain acyl-Co-A synthetase dbj|D10040| 331 95 
U221-P Hmnan lysyl synthetase dbj|D31B90| 205 9® 
T997-F Human macroglobulin, beta-2 ento|X07621| 168 91 
U071-F Mous inosine-5‘-monophosphate dehydrogenase gb|M98333| 213 9® 
T226-F Human manganese superoxide disnutase ento|X65965| 182 86 
T147-F Hmnan metallothionein I-A gb|K01383| 250 69 
T058-F Huroan glycogen 4-alpha-D-glycosytransfcrase gb|U32573| 415 91 
T923-F Hunian nntallothionein I-« gb|m0942| 190 100 
T327-P Human metallothionein I I gb|M26637| 170 95 
T626-r Hmnan roetaaiothionein I I grb|M26637| 305 92 
X994-r Human roetallothioncin from cadium-treated c«lla enb|V00594| 191 100 
X818-r Hiutan metallothionein from cadium-treated c«lls enb|V00594| 220 9A 
T954-F Human nicotinamide nucleotide transhydrogenase gb|U40490| 154 95 
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tn.35-P Hmnan proteasome subunit HsN3 dbj|D26600| 222 ®® 
U115-P Human short chain acyl-Co-A dchydrogenas® gb|M26393| 154 ® ' 
T735-r Huxnan 26S proteas® regulatory *ubunit gb|L02426| 358 f® 
T877-r H»nan ublqultln ffb|M2S880| 223 " 0 
T025-F Huxnan ATP-cltrat« lyas« «nb|X64330| " 4 100 
U214-r Kunan tissuo inhibitor of n»talloproteinas«s-3 gb|U14394| 164 93 
T211-r Human alpha-2-nsicroglobulln r«ceptor-asaociated protcgb|M63959 392 ®® 
T836-r Hwnan ubiquitin gb|M268B0| 238 91 
X814-r Hunan branched chain acyltransfaras® gb|J032081 213 »® 
T006-r Kxunan calpastatin gb|U31345| 253 98 
U164-F Hxunan carbonio anhydras® I I I gb|M29453| 204 »® 
X680-F Huxnan ferritin light chain gb|Ma.ll47| 188 »» 
T686-r Hmnan cathepsin B gb|L22569| 360 91 
T201-F Huxnan cathepsin L gb|L06426| 190 J2 
T736-F Hunian i>biquitln gb|M26880| ^ 2 »« 
T553-P Hmnan tibiquitin-lik® prot®in dbj|D23662| 2 = 99 
T708-P Hunan very-long-chain acyl-CoA dchydrogenaaa dbj|D43682| 303 1 二 
T102-F Hwnan ferritin heavy chain gb|M3_2937| 282 99 
U215-P Kmnan ferritin heavy chain gb|Ma.2937| 300 99 
T692-r Hunan f«rrit in heavy chain gb|Ma.5383| " 6 98 
Ul83-F Human nyoglobin ento|X00373| 219 99 
Xi43-F Human plasma protein S, vitamin K-dcpendent gb|M3-5036| 413 9» 
(9) Signal transduction / ceU regulation 
T909-F H ^ N-ras ento|X02751| 240 92 
T141-P Hunan protein kinase C inhiiitor-I gb|U27143| 452 »» 
T204-r Human pyruvate kinas«, M-2 type gb|M23725| 234 “ 
T036-F iUtEixSma gb|U48247| 210 »0 
T854-F Rat protein tyrosin kinas« JAK2 gb|U13396| 152 ®® 
T115-F Hmnan serine/threonine kinase receptor gb|U20165| 294 二 
T052-F Hvunan serine/threonine kinase receptor gb|U20165| 193 99 
(10) Transcription and translation 
T620-P Hunan ribosomal protein S10 gb|U14972| " 0 ®8 
U100-F Huroan ribosornal protein L27a gb|U14968| " 8 1 二 
T552-F Human ribosoroal protein L27a gb|U14968| 163 »J 
T078-F Hxaaan ribosomal protein L30 gb|M94314| 236 9B 
U110-F H;anan ribosomal protcin L30 «nb|X7£)238| 247 93 
T548-r Hiunan ribosomal protein L37a gb|L22154| 235 »» 
U194-F Hunan ribosonal protein L39 ento|X82551| 19^ »8 
T200-P Human ribosomal protein L4 ^ t | D 2 3 S 6 0 ^42 " 
T380-r HrraanribosonalproteinL26 cnto|X69392| 160 95 
T916-P Hmnan ribosomal protein S14 gb|Ma,3934| 290 99 
T784-F Hmnan ribosona3_ protein S16 gb|M60854| 330 9» 
U211-F Hmnan ribosomal protein S18 cnb|X69150| 177 99 
T667-r Huroan rD>os<ana3. protein S21 gb|L04483| 222 9^ 
T748-F Hunan ribosomal protein S4X gb|M58458| 210 99 
T937-F Hmnan ribosomal protein S4X gb|M58458| 188 ®® 
T944-F Hmnan ribosomal protein S4X gb|M58458| 263 100 
T461-P Human ribosotnal protein S5 gb|U14970| 239 96 
U205-F Hiunan riboscanal prtocin L9 gb|U21138| 290 ^ 
T255-F Human U1 small nuclear BNP-specific C protein crtb|X12517| 252 96 
T153-F Hunan heat shock protein, 90 kDa gb|M16660| 300 «« 
T009-F Huneoi acidic ribosomal phosphoprotein P0 gb|M17885| 250 91 
T753-F Hunan acidic ribosomal phosphoprotein P2 gb|M3.78871 215 98 
T648-F Hmnan zino finger protein, bcl-6 gb|U00115| 205 96 
T051-F Hunan elongation factor 1-alpha gb|L10340| 194 97 
U061-F Human elongation factor 1-alpha gb|M29548| 233 95 
U195-F Hmnan heat shock protein, 70 kDa ento|X04676| 270 98 
T264-F H w a n heat shock protein, 70B' ento|X51758| 266 99 
T065-F Himan heat shock protein, 71 kDa enb|Y00371| 304 96 
T321-r Hmnan ribosomal protein L26 enb|X69392| 294 96 
U032-r Hmnan hnKNP C2 gb|M29063| 284 96 
T623-r Hmnan hnBNP El gb|X7B137| 249 97 
T681-F Hunan honolog of Drosophila enhancer of split gb|U04241| 11A ®8 
T720-r Mouse 60S ribosomal protein gb|U28917| 218 85 
T771-F Htunan nuclear factor p97 gb|L39793| 341 88 
Tl51-F Hmnan ras-like protein gb|M314681 278 92 
T675-r Hunan ribosornal protein L18 gb|L11566| 289 98 
Ul53-r Hunan ril>oson<al protein L23a gb|U02032| 327 96 
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3.3 Sequence analysis of hSP56 
Among the 2244 human fetal heart cDNA EST clones 
that were sequenced by myself and my colleagues (Hwang et 
aL, 1995), one of the human homologues has its DNA 
sequence resembling mSP56. It was named human 56 kDa 
selenium-binding protein (hSP56). The complete cDNA 
sequence was obtained by primer walking (primers sequences 
8a-8h are listed in Appendix 1). The sequence printout of the 
cDNA from the automated sequencing machine named 
Pharmacia ALF sequencer is shown in Fig 3-1. The various 
peaks represent the various bases, which are shown in 
different colours. The DNA sequence of the cDNA clones 
determined both by cycle sequencing and manual sequencing 
(Tsui et a/” 1994) was shown in Fig.3-2. The size of the 
insert as determined by gel electrophoresis of PCR product 
was about 1440 bp and is shown in Fig 3-3. Excluding the 
vector sequences at both ends of the cDNA clone and the 
poly A region, the calculated length of the cDNA insert was 
1419 bp. There is only one hSP56 cDNA sequence amongst 
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Fig. 3-1. A printout of the DNA sequence of hSP56 cDNA obtained from ALF 
Manager. It shows the first 160 base pairs of the fuU length hSP56 sequence. 
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the 2244 fetal heart cDNA clones sequenced in our 
laboratory. When sent to GenBank for alignment, the cDNA 
clone was found to be very similar to a mouse gene which is 
named mouse selenium-binding protein. It is a cDNA which 
was first found in the liver of mouse and the DNA sequence 
of the cDNA clone was introduced in Chapter 1.4. The cDNA 
clone which we obtained was named human 56 kDa 
selenium-binding protein (hSP56) as we first identified it in a 
human fetal heart and it was highly homologues with mouse 
56 kDa selenium-binding protein (mSP56). To study the 
possible open reading frame (ORF) of hSP56, an analysis 
using D N A S I S T M was performed (Fig. 3-2). There are a number 
of possible ORFs for the cDNA sequence. It was found that 
one of those amino acid sequence encoded is very similar to 
that of mouse hSP56. The alignment of mSP56 with hSP56 
suggested that the probable initiation codon is located at 
nucleotide number 15 and the stop codon is located at 
nucleotide number 1434. The 5, UTR has a length of 16 
basepairs and the 3，UTR has a length of 234 base pairs. 
Although no 5, primer extension experiment is done, the 5, 
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Fig. 3-2. The DNA and amino acid sequence of hSP56. The 
start codon (ATG), stop codon (TGA), and polyadenylation 
signal (AATAAA) are underlined. 
1 M A T K C G N C G P G 11 
1 TGT ACC AGT CGC AGC 迎 GCT ACG AAA TGT GGG AAT TGT GGA. CCC GGC 48 
12 Y S T P L E A M K G P R E E I V 27 
49 TAC TCC ACC CCT CTG GAG GCC ATG AAA GGA CCC AGG GAA GAG ATC GTC 96 
28 Y L P C I y R N T G T E A P D Y 43 
97 TAC CTG CCC TGC ATT TAC CGA AAC ACA GGC ACT GAG GCC CCA GAT TAT 144 
44 L A T V D V D P K S P Q Y C Q V 59 
145 CTG GCC ACT GTG GAT GTT GAC CCC AAG TCT CCC CAG TAT TGC CAG GTC 192 
60 I H R L P M P N L K D E L H H S 75 
193 ATC CAC CGG CTG CCC ATG CCC AAC CTG AAG GAC GAG CTG CAT CAC TCA 240 
76 6 W N T C S S C F G D S T K S R 91 
241 GGA TGG AAC ACC TGC AGC AGC TGC TTC GGT GAT AGC ACC AAG TCG CGC 288 
92 N K L V L P S L I S S R I Y V V 107 
289 AAC AAG CTG GTC CTG CCC AGT CTC ATC TCC TCT CGC ATC TAT GTG GTG 336 
108 D V 6 S E P G P Q K L H K V I E 123 
337 GAC GTG GGC TCT GAG CCC GGG CCC CAA AAG CTG CAC AAG GTC ATT GAG 384 
124 P K D I H A K C E L A C L H T S 139 
385 CCC AAG GAC ATC CAT GCC AAG TGC GAA CTG GCC TGT CTC CAC ACC AGC 432 
140 H C L A S G E V M I S S L G D V 155 
433 CAC TGC CTG GCC AGC GGG GAA GTG ATG ATC AGC TCC CTG GGG GAC GTC 480 
156 K 6 N G K G G F V L L D G E T F 171 
481 AAG GGC AAT GGC AAA GGG GGT TTT GTG CTG CTG GAT GGG GAG ACG TTC 528 
172 E V K 6 T W E R P G G A A P L G 二 
529 GAG GTG AAG GGG ACA TGG GAG AGA CCT GGG GGT GCT GCA CCG TTG GGC 516 
188 Y D F W Y Q P R H N V M I S T E 203 
577 TAT GAC TTC TGG TAC CAG CCT CGA CAC AAT GTC ATG ATC AGC ACT GAG 624 
204 W A A P N V L R D G F N P A D V 219 
625 TGG GCA GCT CCC AAT GTC TTA CGA GAT GGC TTT AAC CCC GCT GAT GTG 672 
220 E A 6 L Y G S H L Y V W D W Q R 235 
673 GAG GCT GGA CTG TAC GGG AGC CAC TTA TAT GTA TGG GAC TGG CAG CGC 720 
236 H E I V Q T L S L K D Q L I P L 251 
721 CAT GAG ATT GTG CAG ACC CTG TCT CTA AAA GAT GGG CTG ATA CCC TTG 768 
252 E I R F L H N P S A T Q G F V G 267 
769 GAG ATC CGC TTC CTG CAC AAC CCA AGT GCC ACC CAG GGT TTT GTA GGC 816 
268 C A S A P N I Q R F Y K T R E G 283 
817 TGT GCC TCA GCT CCA AAC ATC CAG CGC TTC TAC AAA ACG AGG GAA GGT 864 
284 T W S V E K V I Q V P P K K V K 299 
865 ACA TGG TCA GTG GAG AAG GTG ATC CAG GTG CCC CCC AAG AAA GTG AAG 912 
300 6 W L L P G V P G L I T D I L L 315 
913 GGC TGG CTG CTG CCA GGG GTG CCA GGC CTG ATC ACC GAC ATC CTG CTC 960 
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con,t Fig. 3-2. 
316 S L D D R F L Y F S N W L H G D 331 
961 TCC CTG GAC GAC CGC TTC CTC TAC TTC AGC AAC TGO CTG CAT GGG GAC 1008 
332 L R Q Y D I S D P Q R P R L T G 347 
1009 CTG AGO CAO TAT GAC ATC TCT GAC CCA CAO AGA CCC CGC CTC ACA. GGA 1056 
348 Q L P L 6 G S I V K G 0 P V Q V 363 
1057 CAG CTC TTC CTC GGA GGC AGC ATT GTT AAG GGA. GGC CCT GTG CAA GTG 1104 
364 L E D E E L K S Q P E P L V V K 379 
1105 CTG GAG GAC GAG GAA CTA AAG TCC CAG CCA GAG CCC CTA GTG GTC AAG 1152 
380 6 K R V A G G P Q M I Q L S L D 395 
1153 GGA AAA CGG GTG GCT GGA GGC CCT CAG ATG ATC CAG CTC AGC CTG GAT 1200 
396 6 K R L Y I T T S L Y S A W D K 411 
1201 GGC AAG CGC CTC TAC ATC ACC ACG TCG CTG TAC AGT GCC TGG GAC AAG 1248 
412 Q F Y P D L I R E G S V M L Q V 427 
1249 CAG TTT TAC CCT GAT CTC ATC AGG GAA GGC TCT GTG ATG CTG CAG GTT 1296 
428 D V D T V K G G L K L N P N C L 443 
1297 GAT GTA GAC ACA GTA AAA GGA GGG CTG AAG TTG AAC CCC AAC TGC CTG 1344 
444 V D F G K E P L G P A L A H E L 459 
1345 GTG GAC TTC GGG AAG GAG CCC CTT GGC CCA GCC CTG GCT CAC GAG CTT 1392 
460 R Y P G G D C S S D I W I * ^ ^ 
1393 CGC TAC CCT GGG GGC GAT TGT AGC TCT GAC ATC TGG ATT 巡 ACT CCA 1440 
1441 CCC TCA TCA CCC ACA CTC CCT ATT TTG GGC CCT CAC TTC CTT GGG GAC 1488 
1489 CTG GCT TCA TTC TGC TCT CTC TTG GCA CCC GAC CCT TGG CAG CAT GTA 1536 
1537 CCA GAC AGC CAA GCT GAG ACT GTG GCA ATG TGT TGA GTC ATA TAC ATT 1584 
1585 TAC TGA CCA CTG TTG CTT GTT GCT CAC TGT GCT GCT TTT CCA TGA GCT 1632 
1633 CTT GGA. GGC ACC AAG AAATAAACT CGT AAC CCT GTC 1668 
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Fig. 3-3. The PCR product of hSP56. 'M, represents 
X / H i n d l l l ' ^ X 174/ H a e l l l size marker. The ‘PCR, indicates 
the target PCR product of hSP56 using pAED4-hSP56 as 
the template. The primers are sequences as described in 
page 50 of the materials and methods section. 
I M PCR I^ H 
bp — ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 
~> ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
bp ~> ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
2027bp — ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ <_ 1440bp 
1353bp - ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 







Fig. 3-4. Hydrophobicity analysis of hSP56 as determined 
by PROSIS™: (Hopp.Thr). The averaging "window" size for 
analysis was set as six. 
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non coding sequence is 9 9 % similar to the mSP56, therefore 
hSP56 is likely to be complete. The ORF of hSP56 has a 
length of 1419 t>ase pairs which codes for 472 amino acid 
residues. The consensus initiation sequence RCCAUGG (R 
represent purine) is present at the start of the ORF and the 
typical polyadenylation signal, AATAAA (Proudfoot and 
Brownlee, 1977) is found at the 3, UTR of the clone. After 
translating the ORF of hSP56, a gene product of 472 amino 
acid residues was obtained with the estimated size of 52250 
dalton as estimated by DNASIS™ • From the hydrophobicity 
analysis of PROSIS™, the protein has no prominent 
hydrophobic region (Fig.3-4) and so it was unlikely to be a 
transmembrane protein. The amino acid content of hSP56 
was shown in Table 3-2. The estimated pI as determined by 
PROSISTM was 6.13 (Fig. 3-5). The DNA sequence of hSP56 
has a similarity of 87.2 % when aligned with that of mSP56, 
respectively. When the amino acid sequence of hSP56 was 
aligned with that of mSP56, 87.3 % identity, 98.7 % 
similarity, respectively, were found. The alignment of the 
DNA sequences between the two cDNA clones is shown in Fig. 
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3-6. From the comparison of DNA and amino acid sequences 
of hSP56 and mSP56, It is highly probable that hSP56 and 
mSP56 are structurally similar to each other because they 
have a high degree of amino acid sequence identity. We 




Table.3-4. Table of amino acid content of hSP56 as 
analysed by D N A S I S ™ . 
+ + + + 
I I I I I ‘ 
I Amino Acid | Mol% | Count | Residue Weight | CNT * RW I 
I I I (CNT) I (RW) I I 
| " l y _ _ _ G — _ I 9 . 9 6 I 4 7 | 5 7 . 0 5 I 2 6 8 1 . 3 5 I 
I A O , a A I 4 . 2 4 | 2 0 | 7 1 . 0 7 I 1 4 2 1 . 4 0 I 
I v a l V I 7 . 4 2 I 3 5 | 9 9 . 1 3 I 3 4 6 9 . 5 5 I 
I L e u L I 1 1 . 0 2 I 5 2 | 1 1 3 . 1 5 I 5 8 8 3 . 8 0 I 
I i i e I I 4 . 8 7 I 2 3 | 1 1 3 . 1 5 I 2 6 0 2 . 4 5 I 
I s e r S I 6 . 7 8 | 3 2 | 8 7 . 0 7 I 2 7 8 6 . 2 4 I 
I T h r T I 4 . 2 4 | 2 0 | 1 0 1 . 1 0 I 2 0 2 2 . 0 0 I 
I C y s C I 2 . 5 4 | 1 2 | 1 0 3 . 1 4 I 1 2 3 7 . 6 8 I 
I M e t M I 1 . 4 8 I 7 | 1 3 1 . 1 9 I 9 1 8 . 3 3 I 
I A s p D I 5 . 9 3 I 2 8 | 1 1 5 . 0 8 I 3 2 2 2 . 2 4 I 
I A s n N I 2 . 9 7 | 1 4 | 1 1 4 . 1 0 I 1 5 9 7 . 4 0 I 
I G l u E I 5 . 5 1 I 2 6 I 1 2 9 . 1 1 I 3 3 5 6 . 8 6 I 
I G l n Q I 3 . 8 1 I 1 8 | 1 2 8 . 1 3 I 2 3 0 6 . 3 4 I 
I A r g R I 4 . 2 4 | 2 0 | 1 5 6 . 1 8 I 3 1 2 3 . 6 0 I 
I L v s K I 5 . 9 3 I 2 8 | 1 2 8 . 1 7 I 3 5 8 8 . 7 6 I 
I H i s H I 2 . 7 5 I 1 3 I 1 3 7 . 1 4 I 1 7 8 2 . 8 2 I 
I P h e F I 2 . 7 5 I 1 3 | 1 4 7 . 1 7 I 1 9 1 3 . 2 1 I 
I T y r Y | 3 . 6 0 | 1 7 | 1 6 3 . 1 7 I 2 7 7 3 . 8 9 I 
I T r p W I 2 . 3 3 | 1 1 I 1 8 6 . 2 0 I 2 0 4 8 . 2 0 I 
I P r o P I 7 . 6 3 I 3 6 | 9 7 . 1 1 I 3 4 9 5 . 9 6 I 
I + + 
TOTAL RESIDUE WEIGHT -> 52232.08 
+) 18.02 
MOLECULAR WEIGHT > 52250.10 
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Fig. 3-5. Estimated pI of hSP56 as determined by 
PROSIS™. 
THB NTJMBER OF CHARGED AMINO ACID 
Arg (R) I 20 pKa = 12,5 
Asp (D) : 28 pKa = 3.9 
CVS (C) X 12 pKa = 8,3 
GlU (B) 1 26 pKa = 4.3 
Hl8 (H) t i3 pKa j： 6.0 
LyS (K) : 28 pKa iv ;^0.5 
Tyr (Y) X 17 pKa 二 i0.1 
N terminal Amino Acid i Met (M) A^A = ^ 
, Clterminal Amino Aoid : lle (I) ^ ¾ = ^,3 
Isoelectric point [pl】=, S.l3 . • • 
Charge • • 
• , . • - • - - • - — . • - , 
% •» • • ••-
0 0 ' 
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eQr-^s^ 
4 : \ 
, y 
0 ~ ~ ^ ^ 
• 2 0 . N^ 
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-50_ N ^ 
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Fig. 3-6. Comparison of DNA sequence of hSP56 and 
mSP56. The alignment was performed using M a c D N A S I S ™ . 
Amino acids that are identical between the two sequences 
are marked by ,:,,that are similar are marked by ‘•,• while 
those that are different are left blank. 
10 20 30 40 50 60 
hsP5 6 MATKCGNCGPGYSTPLEAMKGPREErVYLPCIYBNTGTEAPDYLATVDVDPKSPQYCQVl： 
• « * • « • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • * 二 • * * • 書 眷 參 0 « • « • • • • • • • 
mSP5 6 i^i^ ii^ &i>(^ i^pLEAMKGPBEEr7YLPCrmm3TEAPDYLATVDVDPKSPQYSQVI 
70 80 90 100 110 120 
hsp56 HKLPMPNLKDELHHSGWNTCSSCFGDSTKSBNKLVLPSLISSMYWDVGSEPGPQKLHK 
mSP5 6 ii^iii^Yiii)i:ijli;^!^J^SSCPGDSTKSBNKKELPGLI S SRlYWDVGSEPRAPKLHK 
130 140 150 160 170 180 
hSP56 viEPKDIHAKCELACLHTSHCLASGEVMISSLGDVKGNGKGGFVLLDGETFEVKGTWERP 
mSP56 ;^^i^(i:]^^i;SHCLASGEVM7STLGDLQGNGKGSFVLLDGETFEVKGTWEKP 
190 200 210 220 230 240 
hSP56 GGAAPLGYDFWYQPRHNVMn:STEWAAPNVLRDGFNPADVEAGLYGSHLYVWDWQRHEr7? 
• • • • • • • • • • • • • • • • • _ • • * 參 參 峰 參 奢 • 肇 « • • • • • • • • • • • • • • 參 • • • 參 • 參 • * * 
mSP56 ;i^(^i^;iaiNVMVSTEWAAPNVFKDGFNPAHVEAGLYGSKrFVWDWQRHEIIQ 
250 260 270 280 290 300 
hSP5 6 TLSLKDGLi:i>LEIRFLHNPSATQCTVGCASAPN3:QRFyKTREGTWSVEKVIQVPPICFCN7ia^ 
• • • • • • • • • • • • • • • • • * * * 二 二 : 二 * « C I • • • • • • • • • • • • • • • • • • * * * * * * * * * • mSP56 iio^&ii^iiii^HDPSATQGEVGCASAPOTQMYKNAECTWSVEKVICJVPSKKVKG 
310 320 330 340 350 360 
hsP56 WLLPGVPGLITDILLSLDDRFLYFSNWLHGDU^QYDISDPQBPRLTGQLFLGGS3^7KG^P 
» • 0 • • • • » • • • • • • • • • • • • • • • • • • • • • • • • • - • • 會 • • • _ * * , 書 • « • • • • • • • • 
mSP56 ^^^^&iiii)i:iiiij)i)iiiYFSNWLHGDIRQYDISNPQKPKLAGQIFLGGSrVRGGS 
370 380 390 400 410 420 
hSP56 VQVLEDEELKSQPEPLWKGKRVAGGPQMIQLSLDGKRLYITTSLYSAWEKQFY^?]^? 
mSP5 6 ;&^^^ii^i>iA^iao:PGGPQMIQLSLDGKRLYATTSLYSAWDKQFYPDKtBE 
430 440 450 460 470 
hSP56 GSVMLQVDVDTVKGGLKLNPNCLVDFGKEPLGPALAHELRYPGGDCSSDmi 




3.4 Northern hybridization of hSP56 
Since the homology between hSP56, mSP56 and is very 
high, the hSP56 probe was used to hybridize with total RNA 
of various mouse tissues (Fig.3-7). Total RNA was isolated 
from mouse organs using acid guanidium thiocyanate 
phenol-chloroform extraction. By comparing the location of 
the band with that of 18S and 28S ribosomal RNAs, it was 
found that the hSP56 mRNAs had the size of about 1660 
nucleotides. Since mature eukaryotic mRNAs have a poly A 
tail of 200-300 adenine residues at its 3, end (Wickens, 
1990), the size of the cDNA in the hSP56 clone (about 1440 
nucleotides) would be close to the size of the mature mSP56 
mRNA. For the normalization of the hSP56 signal, p_actin 
cDNA was used as a control probe. To confirm whether we 
have obtained a full length clone which possessed a fuU 
length 5, UTR, primer extension experiments was performed 
to answer the question. It was shown that liver, lung, and 
kidney have the highest signal. A moderate signal could be 
seen in heart ； detectable, but low, signals were found in 
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intestine and spleen. Virtually no signal could be detected in 
skeletal muscle and brain. Previous results have shown that 
SP56 is expressed at a high level in mouse liver, kidney, and 
lung, with a lower level in intestine and barely detectable 
amounts in brain, thymus, muscle, spleen, skin, mammary 
tissues, testis, and ovary (Lanfear et al” 1993; Morrison et 
af” 1989). Such previous results agree well with ours. 
However, here we further show that the expression of SP56 
in mouse heart is at an intermediate level between those 
found in liver/lung/kidney and intestine. 
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Fig. 3-7. Northern hybridization. (A): Key for mouse RNA 
sample: B, brian; H, heart; I, intestine; K , kidney; Li, liver; 
Lu, lung; M , muscle; S, spleen. (B): p-actin for 
normalization 
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3.5 Cloning of hSP56 into pAED4 
Before the expression of hSP56 in E coli, we need first 
ensure that the insert cloned into the vector is at an optimal 
distance to a promoter upstream and is in a correct reading 
frame with respect to the start codon of the vector. 
Therefore, in order to produce the authentic hSP56, we have 
designed a primer which was complementary to the 5, end of 
the ORF. This primer was designed such that the ATG of the 
ORF of hSP56 was able to ligate with the NdeI site of pAED4. 
When hSP56 was ligated with pAED4 through the NdeI 
restriction site, hSP56 was under the control of the T7 
promoter of the vector. At the 3, end, the oligo dT primer 
would prime along the poly A tail of the cDNA clone. The 
cDNA insert that is amplified by PCR is then restricted by 
NdeI and EeoRI and then ligated to the vector pAED4 for 
expression. By using this method, hSP56 was successfully 
amplified. It can be shown that the PCR product of hSP56 
using cloning and dT primer was of a smaller size when 
compared with that using the common PCR primers flanking 
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the cloning site of Xgt22, because the cloning and oligo dT 
primers would remove the vector sequences at 5, and 3, end, 
for example, the 5,UTR and a part of the poly A tail of the 
original hSP56 cDNA clone. The expected size of the PCR 
product was about 1420 bp. There was a range of PCR 
products due to the fact that the dT primer could prime 
along different sites of the poly A region of the 3, end of the 
clone. Individual cDNA clone can be isolated after 
transformation into E. colL 
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3.6 Expression of the hSP56 in E.coli 
The oligo-dT primer can be used as a common 3, end 
cloning primer to amplify the interesting cDNA clones found 
in our human heart cDNA sequencing project. In my study 
project, hSp56 cDNA was successfully amplified using a 
tailor-made cloning primer and an oligo dT primer. This 
strategy is suitable for large scale cDNA sequencing and 
expression project. Some of my coworkers have used this 
strategy to clone and express the genes successfully. The 
former cDNA was amplified from the adult and fetal heart 
cDNA libraries while the latter cDNA was amplified from two 
overlapping clones in the adult heart cDNA library. Their 
successes proved that this strategy is very useful and 
efficient. The success of the directional cloning was proved 
by restriction cutting of the putative recombinant plasmid. 
After transformation, some of the clones which were 
able to grow in LBAC plates were checked for there ability to 
express hSP56. BL21 (DE3) pLysS and BL21 (DE3) pLysE 
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were used as the host. In my experiment, all 12 clones of 
BL21(DE3)pLysE which were picked were able to produce 
hSP56 upon induction by 0.4 m M IPTG. Because the hSP56 
is a small protein of 56 kDa, it runs at the front of the 15 % 
polyacrylamide gel. The expression of hSP56 could be 
checked by comparing the putative clones with a negative 
control that was not induced by IPTG (Fig 3-8). 
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Fig. 3-8. Expression of hSP56 in E. coli BL21(DE3)pLysE. 
SDS-PAGE ofhSP56 with 15 % polyacrylamide gel. Lane 1: 
uninduced recombinant bacterial crude extract. Lane 2: 
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3.7 Chromosomal mapping of the hSP56 gene 
Under the condition used, the hybridization efficiency 
was approximately 8 0 % for the hSP56 probe (among 100 
checked mitotic figures, 81 of them showed signals on one 
pair of the chromosomes). Since the DAPI banding was used 
to identify the specific chromosome, the assignment 
between the signal from probe and the long arm of 
chromosome 1 was obtained. The detailed position was 
further determined based on the summary from 10 photos 
(Fig3-9-A). There was no additional locus picked up by FISH 
detection under the condition used, therefore, probe hSP56 
is located at human chromosome 1, region q21-q22. No 
significant FISH signals were observed from other 
chromosomes. Fig3-9-B shows the mapping results. 
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Fig. 3-9.(A and B) FISH mapping. A: F ISH signals on 
chromosomes one. B: The same mitotic figures stained 




C H A P T E R 4 
DISCUSSION 
4.1 General discussion 
I have sequence 553 adult human heart cDNA clones. I 
assigned putative identities of these clones and set up the 
database and catalogued the results (Table 3-1,3-2,3-3). 
These are parts of sequencing data in our cDNA library data 
pool of our group. 
The catalogue of those 553 cDNA clones may be useful 
for the analysis in future. For example, studies of the 
frequency of cDNA clones that matched to known genes can 
act as an alternative of Northerning blotting (Davies, 1993). 
If we know which genes are expressed in the adult human 
heart, we can estimate the level of expression (Tsui Ph.D. 
thesis 1995). 
Also the categorization of these clones (Table. 3-1) can 
form an expression profile according to their function. It 
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could be used as a reference for a human heart tissue when it 
compared with that other human tissue. When the profile is 
compared with that of human brain, some interesting results 
can be obtained (Adams et aI., 1993). The percentage of 
matches that belong to transcription and translation can be 
used as a reference group because we can assume that the 
protein synthesis machinery is comparable in heart and 
brain. (Tsui Ph.D. thesis 1995). 
On the other hand, the comparisons of the compositions 
and expression profiles between normal human heart cDNA 
library and human diseased heart cDNA libraries can also give 
valuable data on the change in gene expression in the diseases 
state. It may help the studying of human heart diseases 
macroscopicaUy and may lead to breakthroughs in the study of 
multigenic human heart diseases. 
There are 196 clones that belong to human-match 
genes. Only 11 clones have been match to nonhuman genes. 
Similarities to n o n h u m a n genes enable us to speculate on 
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their function in human (Tugendreich et aL, 1993). These 
nonhuman match clones can be used as probes to screen the 
cDNA library for full length clones by hybridization (Bloem et 
aL, 1990) or PCR (Amaravadi et aL，1994). Also , the full 
length cDNA can be generated using human heart mRNA as 
the starting material (Apte et al” 1993; Barnard et al., 1994; 
Weis, 1994). Other EST sequencing groups have used their 
nonhuman matches to clone the human homologs of 
nonhuman proteins (Hori et al., 1994). There are 346 cDNA 
clones that do not match to any known gene and these may 
contain inserts encoding novel genes. These genes may be 
used as the resource for studying gene expression in the 
human heart and for the discovery of new genes. 
Beside the sequencing of 553 cDNA clones, my research 
project focused on the isolation and partial characterization of 
a cDNA encoding the hSP56 protein. To date, this is the first 
selenium binding protein reported in Homo Sapiens. Within the 
cDNA sequence of hSP56, there are no in-frame TGA codons 
which represent the amino acid selenocysteine [Chamber et al., 
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1986]. Therefore, hSP56 may interact with selenium in a 
manner different from the selenoproteins ^utathione 
perioxidase and formate dehydrogenase. This result is in 
accordance to that of mouse SP56 [Bansal et aL，1990]. 
Although the selenium binding proteins have not been show to 
have any specific biochemical functions directly, there is 
evidence that selenium binding proteins may , under some 
conditions, perform a functional role for a short time in 
selenium deficient animals (Walchulewski et al., 1988). 
Concerning the DNA and amino acid sequence, the putative 
hSP56 protein is similar to both mouse SP56 and AP56, with a 
slightly higher simUarity to the former. The DNA sequences 
similarity of hSP56 with those of mSP56 and AP56 are 87 .2% 
and 86 .6% respectively. The amino acid sequence of hSP56 
have 98 .7% similarity and 87.3% identity with mSP56, and 
97.go/o similarity and 86.4% identity with AP56. It thus seems 
that hSP56 protein is the human homolog of mouse SP56. 
The results for the tissue distribution of the homolog of 
hSP56 in mouse tissues are very similar to that reported 
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previously for mSP56 and AP56 whose expressions in liver, 
kidney and lung are the highest [Lanfear et al., 1993】.However, 
we further reported that significant levels of SP56 are present 
in heart. This finding may help to further elucidate the 
function of this protein. 
At present, the physiological role of hSP56 is unknown. 
Evidence has been presented previously for a putative role of a 
58 kDa selenoprotein in growth control in mammalian ceUs 
[Morrison et al., 1988]. When the mouse cDNA of SP56 was 
cloned and sequenced, it was also considered to be a growth 
regulatory protein [Bansal et al., 1990]. However, the fact that 
mSP56 and AP56 cannot be detected in mammary ceUs or 
mammary ceU lines [Lanfear et al., 1993] implies that neither 
mSP56 nor AP56 is the 58 kDa selenoprotein detected in 
mammary ceUs. A 58 kDa selenium binding protein purified 
from mouse mammary epithelial ceUs (MMEC) was used to 
examine wether selenium modulates protein synthesis or is 
just a marker for ceUular selenium status. Previous study 
results suggest that selenium is attached to the 58 kDa 
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protein, but does not regulate either its protein synthesis or its 
functional activity (Sinha et al., 1993). Based on the similarity 
of protein sequences, we believe that mSP56 and AP56 are 
functionaUy similar. Various hypotheses have been proposed on 
the role of AP56 and SP56 in acetaminophen-induced 
hepatoxicity: AP56 and SP56 may have important functions 
which are inhibited by acetaminophen-binding (ultimately 
leading to ceU death); alternatively, AP56 may have a 
protective role as a scavenger of toxic electrophUes or oxidant 
species such as acetaminophen metabolites [Pumford et al., 
1992 ; Lanfear et aL、1993]. Previous reports have suggested 
that acetaminophen detoxification may depend on the 
selenium status of the animal, since acetaminophen-induced 
hepatotoxicity and lipid peroxidation seem to be decreased by 
selenium administration [SchneU et aL，1988; Wendel et aL, 
1981]. Most recently, Burk et al. [1995] reported that 
selenoprotein P, another selenium binding protein, mediates 
the protective effect of selenium supplement treatment on 
liver necrosis induced by free radicals in selenium deficient rat. 




significant amounts. It is of interest to test whether hSP56 can 
mediate the protective effect of selenium supplement 
treatment against free-radicals-induced necrosis of heart tissue 
in selenium deficient animals. ClinicaUy, deficiency of 
selenium can cause heart faUure fSfang et al., 1984】and the 
diseased condition can be aUeviated by selenium 
supplementation. It wiU be of potential clinical significance to 
investigate whether there is any protective role of hSP56 
throughout the selenium supplement treatment of the 
selenium deficient patients. 
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4 .2 The possible roles of hSP56 and m S P 5 6 
The function of hSP56 is stiU unknown. mSP56 and 
hSP56 may have a similar function because they are highly 
homologous in protein sequences. From the previous study 
disscussed in section 4.1, we know that one of the selenium-
binding protein, selenoprotein P has the protective effect of 
selenium supplement treatment on liver necrosis induced by 
free radicals in selenium deficient rat (Bansal et al., 1990; Yang 
et al., 1984). We are interested to find out whether hSP56 or 
mSP56 has the same function as the selenoprotein P. At the 
moment, information is so scarce that it is difficult to make 
new suggestions regarding the function of the hSP56. 
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4.3 Further aspects 
Antibodies against hSP56 have been produced in our 
laboratory but whether these peptide-induced antibody is 
specific for hSP56 or not remains to be determined. In addition 
to studying the function of hSP56, a good antibody is 
necessary for the purification of the native protein using either 
the prokaryotic or the eukaryotic expression system. We can 
also use a two hybrid system to study whether hSP56 has any 
interaction with the proteins. 
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A P P E N D K 1 
primer list 
1. Xgt22-forward PCR primer: 
5,-ATT GGT GGC GAC GAC TCC TGG-3, 
2. Xgt22-reverse PCR primer: 
5,-TTT GAC ACC AGA CCA GGT A-3' 
3. Xgt22-forward fluorescent sequencing primer: 
5'-XGGT GGC GAC GAC TCC TGG AGC C-3, 
4. Xgt22-reverse fluorescent sequencing primer: 
5,-XGAC ACC AGA CCA ACT GGT AAT G-3, 
5. hSP56-ATG primer with Ndel restriction site: 
5'-TAG GGC CAT ATG GCT ACG AAA TGT GGG AAT TG-3, 
6. Oligo-dT primer with EcdRi restriction site: 
5’-TAG GGC GAA TTC TTT TTT TTT TTT TTT-3' 
7. T7 forward primer with fluorescent label: 
5'-XAAT ACG ACT CAC TAT AG-3, 
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8. hSP56 mid primer with fluorescent label 
8(a) 5,-TGC ACA AGG TCA TTG AGC CCA-3, 
nucleotides: (368-388) forward primer. 
8(b) 5'-TGC CCC CCA AGA AAG TGA AGG-3, 
nucleotides: (892-913) forward primer. 
8(c) 5'-CCT TCA CTT TCT TGG GGG GCA-3, 
nucleotides: (892-913) reverse primer. 
8(d) 5,-CCA GAT GTC AGA GCT ACA ATC-3， 
nucleotides: (1408-1428) forward primer. 
8(e) 5,-GAT AGC ACC AAG TCG CGC AAC-3, 
nucleotides: (270-291) forward primer. 
8(f) 5'-GTA TGG GAC TGG CAG CGC CAT-3' 
nucleotides: (704-723) forward primer. 
8(g) 5,-ATC TGG ATT TGA ACT CCA CCC TCA TCA-3, 
nucleotides: (1422-1449) reverse primer. 
8(h) 5,-GAT GTA GAC ACA GTA AAA GGA GGG-3， 
nucleotides: (1297-1320) forward primer. 
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A P P E N D K 2 
The list of 553 cDNA sequences which are novel 
sequences (novel) or match with partial cDNA sequences 
(partial). For the clone number, the first alphabet and the 
foUowing three numbers indicate the identity of the clone in 
our library and the “F” indicateds the cDNA clones were 
sequenced by using forward primer. PUT-ID indicateds the 
putative identity of the clone. ACCESSION and PERCENT-ID 
indicated the name of the database and the accession number 
of the nucleotide sequence that matched with the highest 
score and the matching percentage. LENGTH indicateds the 
number of base pairs sequenced. 
ACCESSION LENGTH PERCENT—ID CLONE PUT—ID gb|U12404| 266 100 
T001-F Human Csa-19 guiui‘4 
T002-F Novel emb|X90568i 218 97 
T003-F Human titin 
T004-F Novel gb|U31345| 253 98 
T006-F Human calpastatin ^K MnnflSi 250 97 T009-F Human acidic ribosomal phosphoprotein P0 gb|Ml/BUDl zou 
T011-F Novel 
T013-F Alu repeats 
T014-F Novel 
T016-F Human mitochondrial genome 
T019-F Novel 
T020-F Human mitochondrial genome 
T022-F Human mitochondrial genome emblX64330| 174 100 
T025-F Human ATP-citrate lyase emb|Xb4^^ui 
T026-F Human mitochondrial genome ,.^,c,,^, 170 78 T027-F Human myosin heavy chain, cardic beta gDiMZSicsM 
T028-F Novel rrV^ iMMS^ A^l 236 99 
T030-F Human NADH-ubiquinone oxidoreductase gD|M"�joi 
T031-F Human mitochondrial genome 
T033-F Novel 
T035-F Novel gb|U48247| 210 90 
T036-F Rat Enigma ^ ' 
T038-F Novel 
T039-F Novel 
^2ir-F lZll myosin light chain 2, ventricular gb|S69022| 160 95 
T045-F Human mitochondrial genome 
T048-F Human mitochondrial genome ^KiTin^4ni 104 97 
T051-F Human elongation factor 1-alpha 5bL10340 194 91 




T057-F Novel qi T058-F Human glycogen 4-alpha-D-glycosytransferase gb|U32573I 41¾ ？上 
T059-F Human mitochondrial genome .. 
T061-F Human myosin light chain 2, cardiac gb|M22815| 380 99 
T062-F Human mitochondrial genome 
T063_F Human mitochondrial genome … . … 
T064-F Human cardiodilation atrial natriuretic factor gb|I01397| 192 二二 
T065-F Human heat shock protein, 71 kDa emb|Y00371| 304 96 
T067-F Novel 
T069-F Repetitive sequence 
T071-F Human mitochondrial genome 
T074-F Human mitochondrial genome ,^^ --_.^ , 。⑶ qo 
T076-F Human myosin light chain 2, ventricular g ^ S ^ ^ ^ 260 二 
T078-F Human ribosomal protein L30 9blM94314| 236 ^8 
T080-F Human myosin light chain 1, ventricular emb|X07373| 247 y/ 
T080-F Human mitochondrial genome 
T081-F Human mitochondrial genome 
T083-F Novel 
T086-F Human mitochondrial genome v^,,MfiiQnni 9is 92 T091-F Human prostaglandin D synthase gb|M61900| 21b yz 
K:r_? S = cardiodilation atrial natriuretic factor gb|M302621 334 : 
T095-F Human desmin 二 二 go T102-F Human ferritin heavy chain gb|M12937| 282 98 
T107-F Novel ^ „v^ "T9ni<^ Ri ?q4 100 Tii5-F Human serine/threonine kinase receptor gb|U20165| z^4 iuu 
^]ll-l ， v e l dbjlD38305| 265 100 T132-F Human Tob „>^1^洲《” ？63 100 T133-F Human troponin T, cardiac 二 ？ 二 452 9 ^ T141-F Human protein kinase C inhibitor-! ^bU2714 3 452 ^8 
T143-F Human plasma protein S, vitamin K-dependent 冗^。^^^ 250 89 
T147-F Human metallothionein I-A 5^^°Jf®^ 7^8 92 
T151-F Human ras-like protein tlulleeo^ 300 86 
T153-F Human heat shock protein, 90 kDa !^iTi^nioi, = 99 
T160-F Human BTG1 . = 二 冗 270 98 Tl62-F Human myosin light chain 2, cardiac gb|M228151 2i0 
T164-F Human mitochondrial genome 
T165-F Ribosomal RNA 
T166-F Novel 
T168-F Human mitochondrial genome 
T170-F Repetitive sequence 






T185-F Human mitochondrial genome ,,^_,..„, • 81 
T187-F Human Fl-ATPase beta subunit emblX035591 206 81 
T189-F Human mitochondrial genome ^,^..^n 1 i«c 96 
T192-F Human desmoplakin gb|J05211| 16b 
T193-F Novel 
T195-F Human mitochondrial genome 
T197-F Human mitochondrial genome 
T198-F Human mitochondrial genome 
T199-F Human mitochondrial genome u^- ,noQ^ c:ni 逼 96 
T200-F Human ribosomal protein L4 ^^:|1D23660| 266 g 
T201-F Human cathepsin L 9bL06426 = 2 
T202-F Rat calsequestrin 9^^^3287 390 
T203-F Human myosin heavy chain, cardic beta 9^l^2166b 二二 
T204-F Human pyruvate kinase, M-2 type 9^ ^^ 2^3725 ^ ^ 
T205-F Human desmin gb|M63391j 280 
T206-F Human mitochondrial genome 
T208-F Ribosomal RNA ^ ,^r.^ r,ac,a oqo 96 T211-F Human alpha-2-macroglobulin receptor-associated protegb|M639iy 。义 
T213-F Novel 
T215-F Novel „v^mii?q?l 365 98 
T216-F Human Ki nuclear autoantigen gD|Uii/yzi 0 
T217-F Human mitochondrial genome ^,„^,.„., ,7, 99 
T218-F Human creatine kinase, muscle gb|M21494| l/>i 
T223-F Novel 
T224-F Novel 
T225-F Novel v,,v^ Rocc; 1 100 86 T226-F Human manganese superoxide dismutase emblX6596b| iBZ 
T235-F Novel 
T236-F Novel 
T247-F Human mitochondrial genome 
T24 9-F Repetitive sequence 
T250-F Human mitochondrial genome 
llll'-l Humal U1 small nuclear RNP-specific C protein ®??'S5nl^' III llo 
T256-F Human creatine kinase, mitochondrial gb|J05401| 235 1UU 
T260-F Human mitochondrial genome ,,„,,.,., • 87 
T262-F Rat integral membrane glycoprotein emD|zzi:3iJl •siu 





T271-F Novel „„„ Qc 
T272-F Human ETS2 emb|X55181| 208 95 
T273-F Novel „-
T285-F Human myosin regulatory light chain emb|X54304| 184 二 
T299-F Human calcium-ATPase gb|M23115| 151 ^^ 
T303-F Novel 
T307-F Novel ..^ Q^ 
T313-F Human metallothionein I-G gb|J03910| 295 9/ 
T315-F Human mitochondrial genome 
T318-F Human mitochondrial genome 
?321-F H u m L ribosomal protein L26 emb|X69392| 294 ^6 
T327-F Human metallothionein II gb|M26637| 170 y) 
T337-F Human mitochondrial genome 
T34slF H u m L cytochrome c oxidase, subunit VIIc emb|X16560| 160 97 
T351-F Human mitochondrial genome … , … … … QA 
T352-F Human glutamate receptor flip isoform gb|U10301| ib>3 外 
T353-F Human mitochondrial genome 
T372-F Novel 
T375-F Novel 
llll'-l H u m L ribosomal protein L26 emb|X69392| 160 95 
T 3 8 6 - F Human m i t o c h o n d r i a l genome ^u- . tMoocc i n q 97 
T390-F Human catenin, alpha db]|D13866| 179 
T393-F Novel 
lWtl Sumai actinin, skeletal alpha-2 gb|M86406| 212 87 
lf2tl lZll brain natriuretic protein gb|M25296| 279 99 
T425-F Novel 
T439-F Repetitive sequence „^,KiYTQfiS7i ?64 96 
T442-F Human troponin T, cardiac = S ^ : \\l 99 
T449-F Human titin = 二 二 fi5 97 
T450-F Human titin T ^ m a ^ n i ^ 9 96 
T461-F Human ribosomal protein S5 5^"JJ?'° III 96 
T466-F Human tropomyosin, skeletal alpha 9b|M19713| 395 ^ 
二：^ 二 二 二 二 二 96 
T475-F Human mitochondrial genome 
T478-F Human mitochondrial genome 
T481-F Human mitochondrial genome 
T484-F Human mitochondrial genome 
T485-F Novel 
T487-F Human mitochondrial genome 
T488-F Repetitive sequence 
T489-F Ribosomal RNA 
T493-F Novel 
T495-F Novel 
T496-F Novel ,,.,. „^, . , f^;a gn 
T503-F Human tropomyosin, skeletal alpha gb|M19714| & y 
T504-F Human mitochondrial genome ^^Kivnsfi^i1 240 98 T505-F Human myosin heavy chain, cardic beta emb|X056311 24U 
T507-F Novel 
T508-F Novel ’. v^^ ivR^ ;"7Qni 饥 75 T509-F Human growth factor inducible intermediate emb|X56/9U| •szi 
T532-F Human mitochondrial genome 
T533-F Human mitochondrial genome �™v^iYn7Acni 1 9 4 68 T538-F Human troponin C, slow skeletal emb|X07897| 丄34 
T 5 4 4 - F Human m i t o c h o n d r i a l genome . , ^ . _ . ^ . , 00c 99 
T548-F Human ribosomal protein L37a 9 = , ? 】 二 ie3 91 
T552-F Human ribosomal protein L27a 5b|U14968| 温 
T553-F Human ubiquitin-like protein ^ i S g ^ Y 242 81 T554-F Human ribosomal protein L9 gb|U09954| Z4z 
T560-F Human mitochondrial genome 
T561-F Novel 
T565-F Human mitochondrial genome v>_,,cni n s 85 
T566-F Human cytochrome c oxidase, subunit Va gb|M22760| 1 '� 
T567-F Novel emb|X90840| 200 76 
T569-F Human axonal transporter emt>iA-
T572-F Human mitochondrial genome ablM69066| 180 98 
T573-F Human moesin Hh^in66904I 201 89 
T576-F Human supressor for yeast mutant ao]iuD 
T578-F Human mitochondrial genome 





T587-F Human mitochondrial genome 
T588-F Human mitochondrial genome 
T591-F Novel ^v^iY<;4"in4i •^ ni 86 T594-F Human myosin regulatory light chain emb|X54304| 301 
T595-F Human mitochondrial genome ^ . , ^.coxcci ,cc qo T596-F Human tumor necrosis factor alpha inducible protein Agb|M59465| 355 98 
T597-F Human mitochondrial genome 
T598-F Human mitochondrial genome ^v^iYQK_i ?93 95 T599-F Human DGCR6 emb|X96484| 293 95 




T606-F Human mitochondrial genome 
T607-F Human mitochondrial genome 
T610-F Human mitochondrial genome 
T612-F Ribosomal RNA 
T613_F Human mitochondrial genome 
T614-F Human mitochondrial genome ,,^.97^^1 379 99 T616-F Human calcyclin gb|J02763| 379 99 
ll20'l S = ribo3omal protein S10 二二；‘“丨 ？；? 1^ 00 
T621-F Human actin, alpha 二 二 ” 丨 III 97 
T623-F Human hnRNP El 二 = 305 92 
T626-F Human metallothionein II 9。二，二^ 二, ；； 
T627-F Human chondroitin/dermatan sulfate proteoglycan 9bM14219 202 ^9 
ig28-F Human membrane glycoprotein 4F2 antigen heavy chain gb|J02939| 345 91 
T629-F Novel 
T630-F Novel 
T637-F Alu repeats 
T638-F Novel 
T639-F Ribosomal RNA 
T640-F Ribosomal RNA 
T641-F Novel 
T642-F Novel 
Jlir-F ;S:idesmin gb|M63391| 153 93 
^eleIr SJ=i zinc finger protein, bcl-6 _U00115| 205 98 
T652-F Novel 
T653-F Alu repeats 
T655-F Novel ^^Kiv74RiQ1 ^50 98 T656-F Human troponin T, cardiac emb|X74819| 350 
T657-F Alu repeats rih—minrum 331 95 
T658-F Human long-chain acyl-Co-A synthetase ^ 二 二 ‘ 323 97 
T660-F Human vinculin ^"' 
T664-F Human mitochondrial genome „v^iT4A_i 325 98 
T665-F Human pyruvate dehydrogenase El-alpha subunit 9^^^®^^° ；^ 94 
T667-F Human ribosomal protein S21 gblL04483| 2 " 
T668-F Novel 
T671-F Human mitochondrial genome 
T672-F Novel gb|M59832| 337 98 
T673-F Human merosin ^ ' 
T674-F Human mitochondrial genome ,,^,_^^. 期 98 
T675-F Human ribosomal protein L18 gb|L11566| 289 
T676-F Novel v^iuoiccRi 100 96 T677-F Human myosin heavy chain, cardic beta 9bM21665 l«« 95 
T679-F Human decorin ^v,Miii47i 188 98 
T680-F Human ferritin light chain . ^.^ 二 二 1 二 i74 98 T681-F Human homolog of Drosophila enhancer ol split gb|U04241| 丄'4 
T682-F Human mitochondrial genome • “_c”n"Ri ^70 89 
T684-F Cow FlFO-ATP synthase complex F0 membrane domain g sugbS70448 ^'^ 
T686-F Human cathepsin B gb|L22569| 360 
T688-F Human mitochondrial genome _ 
T690-F Novel ^KiMi c;^ p^ i 156 98 T692-F Human ferritin heavy chain gblM15383| lbb 
T696-F Human mitochondrial genome 
T698-F Human mitochondrial genome 
T700-F Novel ^KiTziniK9i 384 99 T701-F Human troponin T, cardiac gb|L40162| 384 
T702-F Novel 
T704-F Human mitochondrial genome 
T705-F Human mitochondrial genome ,.„nfi9Qfii 338 99 T706-F Human glycosylated surface protein emb|X06296| ^^« 
T707-F Human mitochondrial genome ,,.,„.,^07, 3n3 100 
T708-F Human very-long-chain acyl-CoA dehydrogenase blL086661 316 97 
T710-F Human porin LqfiS7^8l 385 98 T711-F Human actin depolymerization factor gb|S65738| >30� 
T712-F Novel 
T713-F Novel 
T714-F Human mitochondrial genome ,,„-»„^^, onc 93 
T715-F Human cardiodilation atrial natriuretic factor gb|M30262| 2y� 
T716-F Human mitochondrial genome 
T717-F Novel 
T719-F Novel nhlIJP89171 218 85 
T720-F Mouse 60S ribosomal protein pmblX541631 236 97 
T721-F Human troponin I, cardiac . '...^4 1 196 94 
T722-F Human myosin regulatory light chain emb|X54304| 196 
T724-F Novel 
^726：^ Su:::i troponin C, slow s.eletal -|X07897| 178 98 
T727-F Human mitochondrial genome 
T728-F Novel 
T729-F Human mitochondrial genome 
T731-F Novel T732-F Human mitochondrial genome 
T734-F Human mitochondrial genome ^Kirn949fii ^5p 98 
r735-F Human 26S protease regulatory subunxt g ^ T s 352 98 
lll^'l Human ubiquitin emb,X81788 1 317 98 T741-F Human DS-1 




T746-F Novel … ^ 
T748-F Human ribosomal protein S4X gb|M58458| 210 9/ 
T74 9-F Novel 
T7 50_F Human mitochondrial genome 
T751-F Novel 
T753-F Human acidic ribosomal phosphoprotein P2 gb|M17887| 215 9Q 
T754-F Human mitochondrial genome 
T758-F Alu repeats .. T760-F Human cytochrome c oxidase, subunit VIIc emb|X16560| 257 aH 
T765-F Human mitochondrial genome … … … o>7 
T766-F Human histidine-rich calcium binding protein gb|M60052| 401 y' 
T767-F Novel 
T770-F Alu repeats ,,_,.„._, , ” po 
T771-F Human nuclear factor p97 gb|L39793| 341 88 
T772-F Human mitochondrial genome ._„_-.. , , ” q. 
T773-F Human myosin heavy chain, cardic beta emb|X05631| 177 94 
T774-F Human mitochondrial genome 
T775-F Novel 
T777lr R^t%ascular endothelial growth factor gb|U22372| 303 98 
T781-F Novel 
Vlltl lZll ribosomal protein S16 g _ 6 0 8 5 4 | 33� 99 
T785-F Novel 
T786-F Human mitochondrial genome 
T789-F Human mitochondrial genome 
T790-F Human mitochondrial genome 
T791-F Novel 
^7 95-F HumL prolactin receptor-associated protein gb|M18981| 313 93 
T798-F Human mitochondrial genome 
T801-F Human mitochondrial genome ^^KivmRq7i 215 98 T803-F Human troponin C, slow skeletal emb|X07897| 215 
T804-F Human mitochondrial genome 
T805-F Human mitochondrial genome 
T806-F Novel ,,.,^ i ,^^ i ^n^ Q8 
T808-F Human myosin heavy chain, cardic beta ^ iVvJ；?^!, tVn 99 
T811-F Human interferon-inducible gene l-8U ， 二 � = , � 1 250 ^^ 
T812-F Human leukemia virus receptor 1 gb|L20859| 」；)& 
T813-F Human mitochondrial genome ,, ^ ^^onpi ? n 98 T814-F Human branched chain acyltransferase gblJ03208| zi^ s 




T826-F Human mitochondrial genome 
T828_F Human mitochondrial genome 
T832-F Human mitochondrial genome 
T833-F Human mitochondrial genome ,_^_.„„. ^an 95 
T834-F Human myosin light chain 2, ventricular gb|S69022| zyu 
T835-F Human mitochondrial genome ^K,M9fiRRni 238 97 T836-F Human ubiquitin gb|M26880| 238 
T837-F Human mitochondrial genome 
T838-F Ribosomal RNA 
T839-F Human mitochondrial genome 
T840-F Alu repeats Hv.n m^994QI 357 91 
T841-F Human neurodapl db]|D32249| 3b/ 
T842-F Human mitochondrial genome 
T846-F Alu repeats 
T848-F Alu repeats 
T850-F Novel 
T851-F Human mitochondrial genome 
T852-F Human mitochondrial genome 
T853-F Human mitochondrial genome ,,„,.,„^, ^co 89 
T854-F Rat protein tyrosin kinase JAK2 gblUliiyb| 丄。么 
T855-F Human mitochondrial genome 
T856-F Human mitochondrial genome 
T857-F Alu repeats ,,„^90471 1 5 7 100 
T861-F Human gap junction protein, cardiac emoiA3zs4,i 
T862-F Novel v,,vc>tt;i ¢: 1 9c0 93 
T863-F Human lipoprotein lipase emb|X54516| 252 
T864-F Human mitochondrial genome . � . ,,„_„.^,. . , ” 95 
T865-F Human ATPase coupling factor 6 subunit, mitochondrialgb|M37104| 312 “ 
T870-F Human homolog of rat HREV107-like protein emb|X92814| ^Ub 
T871-F Novel 
T873-F Novel ^7ioqoc^ ” n 85 
T875-F Human thrombospondin-4 emb|Z19585| 210 
T876-F Human mitochondrial genome … , … � … ooo 
T877-F Human ubiquitin ， 9bM26880 ^z^ 
T878-F Human platelet-endothelial tetraspan antigen 3 gblU14650| it>u 
T879-F Novel v^,vcion>M A^ 1 qn T880-F Human myosin regulatory light chain emb|X54304| 417 
T882-F Human mitochondrial genome 
T884-F Novel 
T885-F Novel 
T886-F Novel ,,,,. .^.^, ,^ ;n R4 T888-F Human visinin-like peptide 1 homolog gb|U14747| 260 84 
T889-F Novel 




T896-F Human mitochondrial genome 
T897-F Human mitochondrial genome 
T898-F Novel 
T899-F Novel 
T900_F Human mitochondrial genome … 
T901-F Rat nuclear pore complex protein NUP107 gb|L31840| 380 85 
T902-F Human mitochondrial genome 
T903-F Novel -„ 
T904-F Human CAC and GTG repeat-containing mRNA gb|U00943| 246 二 
T905-F Human myosin heavy chain, cardic beta gb|M21665| 243 97 
= 『 ？ 二 二 二 1 』 二 , vent.icu.ar 二 忠 ^- �� 
? ;^r-? S = : ; SLst cen surface anti,en 24 - l - B - l 222 91 
T914-F Human mitochondrial genome .,„,,.,., ^^n go 
T916-F Human ribosomal protein S14 gb|M13934| 290 99 
T917-F Novel 
T919-F Novel 
T920-F Novel W M i _ ” iqn T923-F Human metallothionein I-e gb|M10942| 190 
T925-F Novel 
T926-F Human mitochondrial genome ^u.T.in.ni ooo 100 
T928-F Human nucleoporin NUP358 . ^ ^ 9^ ^；!^^'° Ill gg 
T929-F Human cardiodilation atrial natriuretic factor gb|M30262| 206 98 
T930_F Human mitochondrial genome 
T931-F Novel 
T936-F Human mitochondrial genome ^HiMRR4SRi 188 98 T937-F Human ribosomal protein S4X gb|M58458| 188 ^» 
T938-F Human mitochondrial genome 
T94 0-F Human mitochondrial genome 
T942-F Novel 
T943-F Human mitochondrial genome ..^.___. , ^ ； , 1 0� 
T944-F Human ribosomal protein S4X gb|M58458| 263 100 
T948-F Human mitochondrial genome 
T949-F Novel 
T950-F Human mitochondrial genome 
T951-F Novel 
T953-F Human mitochondrial genome ,,„,_.„„. ,.. 95 
T954-F Human nicotinamide nucleotide transhydrogenase gb|U404901 li4 i»D 
T958-F Human mitochondrial genome 
T961-F Human mitochondrial genome ^,^_.,„i, ,^n 97 
T964-F Human creatine kinase, mitochondrial gb|J054011 1¾/ ， 
T966-F Human mitochondrial genome 
T969-F Novel 
T970-F Novel 
T972-F Human mitochondrial genome 
T974-F Repetitive sequence ,,^,.... . i>7G 97 
T980-F Human cytochrome c oxidase, subunit VIIb ^^ .lltltV V^t 97 
T982-F Human desmin ^ ! " " ^ ^ J ' llt H 
T989-F Human nucleoporin NUP358 db]jD42063| 186 9B 
T991-F Human mitochondrial genome 
T992-F Repetitive sequence 
^994-F H u m L metallothionein from cadium-treated cells emb|V00594| 191 二0 
T995-F Human titin emb|X69490| 252 98 
T996-F Repetitive sequence ^,^._..,, 湖 oi 
T997-F Human macroglobulin, beta-2 emb|X07621| lbB 
T999-F Human mitochondrial genome ^,.,-.-^_, 謝 96 
U032-F Human hnRNP C2 gb|M29063| 284 
U034-F Human mitochondrial genome 
U036-F Alu repeats 
U040-F Human mitochondrial genome … , … … i^ ;q tn 
U042-F Human tropomyosin, skeletal alpha 9bM19714 1 " 
U043-F Human cytochrome bc-1 complex core protein II gblJ049 /^ l 丄>3上 
U046-F Human mitochondrial genome 
U04^F Cow^ATP synthetase, mitochondrial epsilon subunit emb|M16978| 211 88 
U049-F Human mitochondrial genome 
U050-F Novel ,,^_^^ot^. -nn q4 U051-F Human OXAlHs emb|X80695| 208 94 
U056-F Human mitochondrial genome v^_vc_*7i Qi q 83 U057-F Cow NADH ubiquinone oxidoreductase, MLRQ subunit emb|X6489M Jiy °^ 
U059-F Human mitochondrial genome 
U060-F Human mitochondrial genome ,,^,-..._. ,,, 95 
U061-F Human elongation factor 1-alpha gb|M29548| 233 
U062-F Human mitochondrial genome 
U063-F Novel 
U064-F Human mitochondrial genome 
U066-F Human mitochondrial genome ,,^__.._. ” � 07 
U067-F Human major nuclear matrix protein gb|M63483| 2iU 
U068-F Novel ,,„.„_-.. ,1, qo 
U071-F Mouse inosine-5'-monophosphate dehydrogenase ^^ J^ ®^^ ： !^, ilt „ 
U072-F Human actin, cardiac alpha ^S^l^2oo?^' ]ll 97 








U093-F Human mitochondrial genome 
U097-F Novel 
=�lZll ribosomal protein L27a _ U 1 4 9 6 8 | 238 100 
U101-F Human mitochondrial genome 
U102-F Human mitochondrial genome 
U104-F Human mitochondrial genome 
U109-F Human mitochondrial genome ^^u,v7Q9^Ri 947 93 
U110-F Human ribosomal protein L30 . ! ^ Jlonfn 111 69 
U112-F Human skeletal muscle 190 kDa protein ®^'^'f'°' ^ ] H 
Ull5-F Human short chain acyl-Co-A dehydrogenase gb|M26393| 154 89 
Sir.F lZ:l actin, cardiaca_a gb|J00068| 242 94 
U118-F Alu repeats 
U120-F Human mitochondrial genome 
U121-F Human mitochondrial genome . ,,.,^..^.. , i^ 7^ 95 
U122-F Human malate dehydrogenase, cytosolic == ！？？二二‘ lVl 92 
U128-F Human pl90-B 卯丨口丄 
U130-F Human mitochondrial genome 
U131-F Human mitochondrial genome 
S34：? lZll cytochrome c oxidase, subunit VIIc =丨二二丨丨 222 98 
U135-F Human proteasome subunit HsN3 db]|D26600| 222 
U136-F Novel 
U140-F Human mitochondrial genome 
U141-F Human mitochondrial genome 
U146-F Novel 
Ul48-F Human inositol phospholipid assembly protein gb|S74 936| 31� 98 
U14 9-F Novel 
U150-F Alu repeats 
U151-F Human mitochondrial genome „ h i _ m 7 i 327 96 U153-F Human ribosomal protein L23a gb|U02032| 327 
U154-F Human mitochondrial genome 
U155-F Human mitochondrial genome 
U157-F Human mitochondrial genome • … … … oni QR Ui59-F Human ubiquinol cytochrome c reductase core I proteingb|L16842| 2// 
U160-F Alu repeats 
U161-F Novel 
Sef-F l Z l l carbonic anhydrase III gb|M29453| 204 96 
U165-F Novel 
U167-F Alu repeats ^ ,^^c^on. r^ Ai Qfi 
U171-F Human crystallin, alpha B ^^Jf^^"® , [i] 98 
U174-F Human cytochrome c oxidase, subunit VIc emblX13238| 197 
U175-F Human mitochondrial genome ,,^...-p. ifi7 98 U176-F Human glucose phosphate isomerase gb|M55538| lb/ 
U177-F Alu repeats 
SssIp r = _ g l o b i n e_X00373|2 219 99 
U185-F Repetitive sequence o„hiYA7SMI 194 88 
U194-F Human ribosomal protein L39 ^ J n ^ ^ 7 ^ 07n 98 U195-F Human heat shock protein, 70 kDa emb|X04676| 270 
U198-F l Z l n myosin alkali light chain, ventricular 9^|^^248 1 252 9^ 
U202-F Human beta-sarcoglycan dystrophin-associated glycoprogbU2 9586 19^ 
U203-F Human cytochrome bc-1 complex core protein II ^. „°^ '； H n 97 
U205-F Human ribosomal prtoein L9 gb|U21138| 2yu 
U206-F Novel 
U207-F Human mitochondrial genome 
U208-F Novel 
U210-F Human mitochondrial genome ^^Kiv^Qisni 177 98 
U211-F Human ribosomal protein S18 二 二 二 ^ 220 98 
U212-F Human nucleoporin-like protein emblX89478| 220 
U213-F Novel ^ ,,,„ .--. . , f^A 93 
U214-F Human tissue inhibitor of metalloproteinases-3 9^"14 394 ^二 
U215-F Human ferritin heavy chain gbjM12937| 300 
U216-F Human mitochondrial genome ,,„,.„,,. 9 ” 96 
U216-F Human highly basic protein, 23 kDa emb|X56932| 231 
U219-F Human mitochondrial genome 
U220-F Human mitochondrial genome HKnin^iRPm 205 99 U221-F Human lysyl synthetase db]jD31890j 205 
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